CA2092205A1 - Soluble melanin - Google Patents
Soluble melaninInfo
- Publication number
- CA2092205A1 CA2092205A1 CA002092205A CA2092205A CA2092205A1 CA 2092205 A1 CA2092205 A1 CA 2092205A1 CA 002092205 A CA002092205 A CA 002092205A CA 2092205 A CA2092205 A CA 2092205A CA 2092205 A1 CA2092205 A1 CA 2092205A1
- Authority
- CA
- Canada
- Prior art keywords
- melanin
- soluble
- dihydroxyindole
- reaction mixture
- enzymes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 title claims abstract description 322
- 102000004190 Enzymes Human genes 0.000 claims abstract description 68
- 108090000790 Enzymes Proteins 0.000 claims abstract description 68
- YFTGOBNOJKXZJC-UHFFFAOYSA-N 5,6-dihydroxyindole-2-carboxylic acid Chemical compound OC1=C(O)C=C2NC(C(=O)O)=CC2=C1 YFTGOBNOJKXZJC-UHFFFAOYSA-N 0.000 claims abstract description 48
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 claims abstract description 24
- SGNZYJXNUURYCH-UHFFFAOYSA-N 5,6-dihydroxyindole Chemical compound C1=C(O)C(O)=CC2=C1NC=C2 SGNZYJXNUURYCH-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000004033 plastic Substances 0.000 claims abstract description 12
- 229920003023 plastic Polymers 0.000 claims abstract description 12
- 239000011521 glass Substances 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 9
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 9
- 230000000475 sunscreen effect Effects 0.000 claims abstract description 8
- 208000003367 Hypopigmentation Diseases 0.000 claims abstract description 6
- 208000000069 hyperpigmentation Diseases 0.000 claims abstract description 6
- 230000003810 hyperpigmentation Effects 0.000 claims abstract description 6
- 230000003425 hypopigmentation Effects 0.000 claims abstract description 6
- 239000012770 industrial material Substances 0.000 claims abstract description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 54
- 239000000203 mixture Substances 0.000 claims description 36
- 230000015572 biosynthetic process Effects 0.000 claims description 24
- 239000011541 reaction mixture Substances 0.000 claims description 24
- 108010051081 dopachrome isomerase Proteins 0.000 claims description 15
- 102000003425 Tyrosinase Human genes 0.000 claims description 13
- 108060008724 Tyrosinase Proteins 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 12
- 230000003287 optical effect Effects 0.000 claims description 11
- 238000003786 synthesis reaction Methods 0.000 claims description 11
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 claims description 9
- 101000773083 Homo sapiens 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 claims description 9
- 108010000410 MSH receptor Proteins 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 9
- 229910021645 metal ion Inorganic materials 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 7
- IGGVVGHJSQSLFO-UHFFFAOYSA-N indole-5,6-quinone Chemical compound O=C1C(=O)C=C2C=CNC2=C1 IGGVVGHJSQSLFO-UHFFFAOYSA-N 0.000 claims description 6
- HVGQWHMSVYODLJ-GFCCVEGCSA-N melanochrome Natural products CC1(C)Oc2cc3OC(=CC(=O)c3c(O)c2C[C@H]1O)CO HVGQWHMSVYODLJ-GFCCVEGCSA-N 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 5
- 239000001506 calcium phosphate Substances 0.000 claims description 4
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 4
- 235000011010 calcium phosphates Nutrition 0.000 claims description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 4
- 238000002211 ultraviolet spectrum Methods 0.000 claims description 4
- 238000001429 visible spectrum Methods 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 238000010257 thawing Methods 0.000 claims description 3
- 238000011200 topical administration Methods 0.000 claims description 3
- 235000013405 beer Nutrition 0.000 claims description 2
- 235000015243 ice cream Nutrition 0.000 claims description 2
- 239000004005 microsphere Substances 0.000 claims description 2
- 235000013606 potato chips Nutrition 0.000 claims description 2
- 235000013618 yogurt Nutrition 0.000 claims description 2
- 239000012062 aqueous buffer Substances 0.000 claims 1
- 239000003086 colorant Substances 0.000 abstract description 6
- 235000015041 whisky Nutrition 0.000 abstract description 2
- 241001122767 Theaceae Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 17
- 230000002255 enzymatic effect Effects 0.000 description 15
- 239000000284 extract Substances 0.000 description 15
- 239000000872 buffer Substances 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 12
- 238000002156 mixing Methods 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- -1 e.g. Substances 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 239000001488 sodium phosphate Substances 0.000 description 8
- 229910000162 sodium phosphate Inorganic materials 0.000 description 8
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 description 6
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 239000010432 diamond Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 108090001090 Lectins Proteins 0.000 description 4
- 102000004856 Lectins Human genes 0.000 description 4
- FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 239000002523 lectin Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 3
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 238000005349 anion exchange Methods 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 201000001441 melanoma Diseases 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XAWPKHNOFIWWNZ-UHFFFAOYSA-N 1h-indol-6-ol Chemical compound OC1=CC=C2C=CNC2=C1 XAWPKHNOFIWWNZ-UHFFFAOYSA-N 0.000 description 2
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- BNSTVBLCTRZUDD-KEWYIRBNSA-N N-[(3R,4S,5S,6R)-2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]acetamide Chemical compound CC(=O)NC1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BNSTVBLCTRZUDD-KEWYIRBNSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 150000003668 tyrosines Chemical class 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- WHNCXIBKVUPNHR-UHFFFAOYSA-N 3,4-dihydroxy-1h-indole-2-carboxylic acid Chemical compound C1=CC(O)=C2C(O)=C(C(=O)O)NC2=C1 WHNCXIBKVUPNHR-UHFFFAOYSA-N 0.000 description 1
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241001441699 Ariidae Species 0.000 description 1
- 241001276409 Ariopsis felis Species 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010036229 Post inflammatory pigmentation change Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 241001233037 catfish Species 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 229920000140 heteropolymer Polymers 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 239000000815 hypotonic solution Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- JDWYRSDDJVCWPB-LURJTMIESA-N leucodopachrome Chemical compound OC1=C(O)C=C2N[C@H](C(=O)O)CC2=C1 JDWYRSDDJVCWPB-LURJTMIESA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000004758 synthetic textile Substances 0.000 description 1
- 210000000160 tapetum lucidum Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000000954 titration curve Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000016776 visual perception Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/47—Addition of dyes or pigments, e.g. in combination with optical brighteners using synthetic organic dyes or pigments not covered by groups A23L5/43 - A23L5/46
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B69/00—Dyes not provided for by a single group of this subclass
- C09B69/10—Polymeric dyes; Reaction products of dyes with monomers or with macromolecular compounds
- C09B69/104—Polymeric dyes; Reaction products of dyes with monomers or with macromolecular compounds containing an indole dye, including melanine derivates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Cosmetics (AREA)
Abstract
A melanin that is soluble in an aqueous solution at a pH of at lest 5 to 9 at a temperature of 0 to 100 ·C. The melanin is further characterized by being capable of being filtered through at least a 0.45 micron size filter. Still further, the melanin is characterized by having a molecular weight of greater than 10,000 kilodaltons. The melanin is useful for providing a naturally-appearing tan to mammalian skin and hair. Such melanin can be produced by combining dopachrome and 5,6-dihydroxyindole (or allowing dopachrome to spontaneously form 5,6-dihydroxyindole) and an appropriate enzyme or by combining 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid or by incubating 5,6-dihydroxyindole-2-carboxylic acid alone. The melanin is also useful for providing a sun-screen to mammalian skin and hair, to treat post-inflammatory hypo- and hyperpigmentation, to tint glass and plastic, to protect industrial materials against ultraviolet damage, and as a coloring agent in foodstuffs such as coffee, tea, soda, whiskey and liquors.
Description
~92/l6l89 ~'PCT~9llO~
SOLUBLE MELANIN
CROSS-REFERENCE TO REL~TE~ APPLICATIONS
This application is a continuation-in-part application of application Serial No. 07/603,111, filed October 25, 1990, now pending, which is a continuation-in-part application of application Serial No. 07/525,944, filed May 18, 1990, now pending.
BACKGROUND OF THE INVENTION
Field of the Invention The present invention concerns the synthesis of soluble forms of melanin and their composition, and methods of using such compositions to provide a naturally-appearing tan to mammalian skin and hair and to provide a sun-screen, to treat post-inflammatory hypo- and hyperpigmentation, to tint glass and plastic, and to protect industrial materials against ultraviolet damage.
Back~round Information In biology, melanins are heteropolymers consisting of L-dopa and its enzymatic derivatives. They are ubiquitous in living organisms and are produced throughout the zoological and botanical phyla. In mammalian skin, melanins are produced through enzymatic processes in specialized cells known as "melanocytes". Melanins are the ~-pigments of mammalian skin and hair.
Mammalian melanins are highly insoluble and can be dissolved (solubilized) only through non-physiological treatments such as boiling in strong alkali, or through the use of strong oxidants such as hydrogen peroxide.
Tyrosinase, a key enzyme in the melanin biosynthetic -pathway, can catalyze the formation of melanin in a test , tube using L-tyrosine, L-dopa or 5',6'-dihydroxyindole as substrates, however, the product is an insoluble precipitate as described above. - ~-:
. .
SUBSTITUTE SftEET
... .
:;, . . . - . - i ~.
. -" . . ~.. . - , , " .. . . - - ; ` , ~ .
wo92"6~89 ~n~ PCT/US91/0~6~
Ito, "Reexamination of the Structure of Eumelanin", 8iochimica et BioPhYsica Acta, 883, 155-161, 1986, mentions natural melanin may ~e a polymer of 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid.
Ito, however, does not teach or suggest com~ining these chemicals to form melanin.
Ito and Nicol, "Isolation of Oligimers of 5,6-Dihydroxyindole-2-carboxylic Acid from the Eye of the Catfish", ochemical Journal. 143, 207-217, 1974, mention that oligimers of 5,6-dihydroxyindole-2-carboxylic acid exist in nature, for example in the tapetum lucidum of the sea catfish (Arius felis). Ito and Nicol, however do not teach or suggest that these structures could be used as a form of soluble melanin.
Palumbo, d'Ischia, Misuraca, and Prota, "Effect of metal ions on the rearrangement of dopachrome", Biochimica et BiophYsica Acta, 925, 203-209, 1987, mention that the metal ions Cu2, Ni2, and Co2 are effective in inducing the non-decarboxylative rearrangement of dopachrome at physiological pH values, leading mainly to the formation of 15,6-dihydroxyindole-2-carboxylic acid. They suggest that when considered in the light of the known metal accumulation in pigmented tissues, their results provide a new entry into the regulatory mechanisms involved in the biosynthesis of ~elanin. Palumbo et al, however, do not teach or suggest that such metal ions could be used to affect the color or formation of soluble melanin. Likewise, Leonard, Townsend, and King, "Function of Dopachrome Oxidoreductase and Metal Ions in Dopachrome Conversion in the Eumelanin Pathway",.
Biochemistrv, 27, 6156-6159, 1988, present similar results to those of Palumbo et al regarding metal ions and the formation of 5,6-dihydroxyindole-2-carboxylic acid from dopachrome. Like Palumbo et al, Leonard et al also do not teach or suggest that such metal ions could be used to SUBSTIT~)TE ~i#EEr , .. ~....... . . .
..... . . . .. .. ... . .
. -.. .. .... -,,.. . .: ~, .
W09~/161X~ ~Tl~S~IJO~
affect the color for formation of soluble melanin.
Many reports exist exploring the role of sulfhydryl compounds such as cysteine or glutathione in determining the red or yellow colors in melanin (see review by Pawelek and Korner, "The Biosynthesis of Mammalian Melanin", American Scientist, 70, 136-145, 1982). However these reports do not teach or suggest that said sulfhydryl compounds could be used to influence the colors of soluble melanins.
It would be of commercial value to have forms of melanin which are soluble at physiological pH and temperature. Such melanins could be applied evenly to mammalian skin and hair in appropriate vehicles without any of the caustic side-effects arising from the harsh reagents needed to solubilize precipitated melanins.
Such solubilized melanins could impart a naturally-appearing tan to mammalian skin and hair.
Solubilized melanins would also be effective as sun-screens, since melanins are the chemicals in the s}cin which absorb ultraviolet radiation and thus provide protection from its harmful effects, such as premature skin aging and the occurrence of skin cancers.
Such solubilized melanins would be effective to treat post-inflammatory hypo and hyper-pigmentation due to eczema, acne, trauma, burns and psoriasis. Also, as a cover-up for vitiligo and other disorders of hypopigmentation, soluble melanins would be quite effective.
Since melanins absorb light throughout the ultraviolet and visible spectra, solubilized melanins would also be effective as glass or plastic tinting agents for eye glasses, contact lenses, car windows, house windows, office buildings, etc.
Likewise, by absorbing in the ultraviolet range, solubilized melanins would be effective agents to protect SUBSTITUTE SHEET
. . ., .. ; ~ . :
: :. ' ' - `. ': ' -W092/16189 2 ~ PCT/~Sg1/o~
industrial materials against damage from ultraviolet radiation. By "industrial material" or "industrial product"
is meant, for example, truck and car tires, paints, laminating materials, plastics, synthetic resins, and fabrics, particularly fabrics containing nylon, and like materials or products. It is well known that the rate of deterioration of paints, wood, plastics and rubber is dramatically increased by exposure to ultraviolet radiation.
SUMMARY OF THE INVENTION
It is the object of the present invention to provide solubilized forms of melanin at physiological pH and temperatures.
It is another object of the present invention to provide compositions and methods for applying such melanins to mammalian skin and hair to provide a naturally-appearing tan.
It is another object of the present invention to provide compositions and methods for applying such melanins to mammalian skin and hair to provide a sun-screen.
It is another object of the present invention to provide compositions and methods of applying such melanins to skin to treat hypo- or hyperpigmentation. ;
It is another object of the present invention to provide compositions and methods for applying such melanins to glass and plastic to provide tint.
It is another object of the present invention to -~
provide compositions and methods for applying such melanins to industrial products to provide protection against ultraviolet radiation.
It is another object of the inventio to provide coloring and/or flavoring agents based on soluble melanin for foodstuffs such as coffee, tea, soda, whiskey, liquor, and the like.
SUBSTITUTE SHEET
- . . , .- - .
., . ....... ~ . . j .` . . . . . . . . - . ~ . . .` . . : -W092/161~ , PCT/~'S91/0 h ~.~ v !~ ,.; . i The above objects and other objects, aims, and advantages are satisfied by the present invention. The present invention relates to a melanin that is soluble in aqueous solution, e.g., water or an aqueous buffered solution, at a pH of at least 5 to 9, preferably 6.5 to 7.5, at a temperature of 0 to 100C. The soluble melanin is further characterized by being capable of being filtered through at least a 0.45 micron size filter. The solubility of the melanin is in large part due to the abundance of carboxyl-groups.
The present invention also concerns a method of producing solubilized melanin comprising combining in a reaction mixture dopachrome and one or more enzymes derived from biological cells or tissues which have a pigmentary system. 5,6-dihydroxyindole may be added to the dopachrome and enzyme(s) or dopachrome may be allowed to spontaneously form 5,6-dihydroxyindole before adding the enzyme(s).
Alternatively, the reaction mixture may comprise 5,6- -dihydroxyindole-2-carboxylic acid alone or in a mixture with 5,6-hydroxyindole, in which case enzymes are not necessary and the reaction occurs in the presence of oxygen.
The color of the soluble melanin can be varied between black, brown, red and yellow by altering the contents of the reaction ~ixtures, for example by adding sulfhydryl containing compounds, or various metals such as, but not limited to, Cu2', Ni2', and Co2~ or by altering the pH
of the reaction mixtures.
The basis for the solubility of the melanin is in a large part due to the high degree of carboxyl groups present in the molecule, said carboxyl groups being incorporated as part of the 5,6-dihydroxyindole-2-carboxylic acid precursor. Compounds similar to 5,6-dihydroxyindole-2-carboxylic acid could substitute in providing said carboxyl groups and could therefore also act as precursors to soluble BSTITU, E SHEET
- , ., ~ , . ~ -:
... . . .
, ~ . . . . .
. , . ~: ,.: .-.
W092/l6189 PCT/US91/0 ~ 6 melanin.
~RIEF DESCRIPTION OF T~E DRAWINGS
Fig. 1 depicts a photograph showing the enzymatic formation of soluble melanin according to the invention.
Non-enzymatically formed soluble melanin is similar in composition to that seen in the tubes labelled "DI Complex".
Fig. 2 depicts a graph showing the optical density (O.D.) of soluble melanin according to the invention at wavelengths greater than 300 nm.
The soluble melanin was synthesized non-enzymatically by mixing 5,6-dihydroxyindole (DHI) and 5,6-dihydroxyindole-2-carboxylic acid (DHICA). The closed diamonds represent a fresh, non-incubated mixture of DHI and DHICA where no soluble melanin was present. The open sguares represent the same mixture incubated 18 hours at room temperature in the presence of oxygen during which time soluble melanin was synthesized.
The high absorbance peaking between 310-320nm is characteristic of the presence of DHICA in the melanin. The broad absorbance over the range from 400-600nm is due in the presence of visible color, characteristic of soluble melanin. Shown here are absorbance spectra in the "ultraviolet A" range and higher. Not shown are the strong absorbance spectra of the soluble melanin in the ultraviolet B and C ranges.
Fig. 3 depicts a graph showing the optical density (O.D.) of soluble melanin according to the invention at wavelengths greater than 300 nm. The soluble melanin was synthesized non-enzymatically as in Fig. 2 under either aerobic (closed diamonds) or anaerobic conditions (open square). It can be seen that oxygen increases the amount of absorbance in the 400-600nm range, i.e., the amount of visible color. -~
':
SUBSTITUTE SHEET
...... ~ ... . , .. :
. . . - . .
. - - .. :
. . . . . . .. .,:
W092/16189 ;;. PCT~US91/0~ ~
k i Fig. 4 depicts a graph showing the optical density (O.D.) of soluble melanin according to the invention at wavelengths greater than 300 nm. The melanin was synthesized either non-enzymatically by mixing DHI and DHICA
(closed diamonds) as described in Figs. 2 and 3; or enzymatically by mixing dopachrome isomerase enzyme complex (DI) with dopachrome and DHI (open diamonds), or by mixing DI with only DHI (open squares), or by mixing DI with DHI
plus DHICA (closed squares). The results demonstrate that en7ymatic and non-enzymatic methods for synthesizing soluble melanin yield comparable products. They also demonstrate the necessity of DHICA or a compound similar to DHICA in the reaction mixtures.
Figure 5 depicts a graph showing the optical density of soluble melanin synthesized non-enzymatically at pH 7. The reaction mixtures were comprised of a mixture of DHICA and DHI (closed diamonds) or DHICA alone (open squares). The results demonstrate that at pH 7 more visible melanin (400-600 nm) is synthesized with a mixture of DHI
and DHICA than with DHICA alone.
Figure 6 depicts a graph showing the optical density of soluble melanin synthesized non-enzymatically at pH 8. The reaction mixtures are otherwise the same as those in Figure 5. The results demonstrate that at pH 8, DHICA
alone can serve as an efficient precursor to the formation of soluble melanin and in fact is somewhat superior to a mixture of DHICA and DRI.
Figure 7 depicts a graph showing a pH titration curve as increasing amounts of acetic acid are added to a ;
solution of 2mM soluble melanin.
Figure 8 depicts a graph showing the precipitation of soluble melanin durinq the pH titration shown in Figure 7. For each point, acetic acid was added and the solution was allowed to sit at room temperature before being filtered SUaSTlTUTE SHE~T
,' ` . .. ` ~ . .. . . .
. . . ':.. ~ .
` : `: '. ~ . ~ .
W092/16189 PCT/US91/0~ ~ _ ~0~ 8 through a 0.45 micron filter. The optical density of the filtrate was then determined at 500nm. The soluble melanin begins to precipitate below pH4, i.e. as the pK of the carboxyl groups is reached. The results are consistent with the solubility of the melanin being determined by the number of non-protonated carboxyl groups present in the molecule.
DETAILED DESCRIPTION OF T~E INVENTION
The soluble melanin of the invention remains in aqueous solution, at neutral pH (e.g., pH of 5 to 9, preferably 6,5 to 7.5), for long periods of time, e.g., indefinitely, at temperatures of 0C to 100C, e.g., room temperature. The soluble melanin according to the invention is further characterized by remaining soluble upon freezing/thawing. The inventive soluble melanin is also characterized by being capable of being filtered through at least a 0.45 micron size filter. The solubIe melanin according to the invention can be precipitated below pH4.
Following synthesis, the soluble melanin cannot be dialyzed through a semi-permeable membrane which allows the passage of molecules having less than a molecular weight of approximately lO,OOO. Therefore the soluble melanin according to the invention is of a molecular weight greater than lO,OOO, however, this is not an essential characteristic for its usefulness. The soluble melanin can be lyophilized to a dry powder form and then reconstituted -to its soluble form with distilled water or suita~le aqueous solvents, e.g., sodium phosphate O.lM or sodium chloride O.lM. It can also be reconstituted in organic solvents such as butanol or 2-butoxyethanol.
The soluble melanin according to the invention can be prepared non-enzymatically (synthetically) or e~zymatically.
The enzymatic preparation according to the invention comprises combining in a reaction mixture a SUBSTITUTE SHEET
. " ' .. , - ' . . ... . . . - .
. `
W~42/16~84 ? ~ '~ `pç~y;u$9l/o346q , V
substrate, i.e., dopachrome, and one or more enzymes derived from biological cells or tissues which contain a pigmentary system and more particularly have the ability to produce melanin.
In the non-enzymatic preparation according ~o the invention, the reaction mixture comprises as a substrate 5,6-dihydroxyindole-2-carboxylic acid (DHICA) alone or a mixture of DHICA and 5,6-dihydroxyindole. Suitable analogs of DHICA, i.e. similar structures containing carboxyl groups, maybe substituted in the reaction. The enzymatic or nonenzymatic reaction mixtures may still further comprise as a substrate indole-5,6-quinone and/or melanochrome. Metal ions and sulfhydryl-containing compounds may be included.
The individual components of the sùbstrate, be it one component, i.e., dopachrome, as in the enzymatic preparation, or more than one component as in the nonenzymatic preparation, preferably will be in an amount of .01 to 5.0 millimolar, but not necessarily limited to this concentration range. Stated otherwise, when more than one component is used, the components, i.e., a mixture of 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid, will preferably be in equal proportions or near to equal proportions.
The combining of substrate and enzymes or substrates in the reaction mixture is preferably conducted at a temperature of 15C to 37~C.
It is preferred in both the enzymatic and nonenzymatic preparation that oxygen, e.g., air or pure oxygen, be present. This is especially true for the nonenzymatic preparations.
Structural formulas and the relationship among some of the above described compounds are depicted as follows:
S~JÇ~T~TUTE SI~EEi~
' . ' ' ` .
' , ' ' ' WO 92/1618~ ') Pcr/US9l/0346 Schen~e "~/ , " , .
~ S A ~ ~ t ~; S ~ C ~
: ~ o o ~ o c ll ro rl ~ J ~
Ii^,/ ; ~' :, " ~ "~
5,6~aln~cro-~UIraolc ~,G-al~ aro~ c~
~Olil) ~cheme II
~IJ~ CCO' ~< .. _ `` -'' -;. ~ ~-~cuco Oooocl\rcmc ~Ci~crilrcmr , ~~coo' ~) tl h ~ / ~ X _ ~,, \ . / )-'^ ~`- ' D^~c Ouinonc ~~
N 1~'\.' ~ ~ ~ ~ i i~ ~, c r ^ x , ~r_S r.~S~ I, \
,coc~
-;In~cro:yio~i cn~lolo:iin^ = r~
_ ,, \ ~, , _ .
~ osincse \ \ ~
~,><~,!~COOII Mci"~
o~
~,~OSir1r : .
SUBSTITUTE SHEET
... , . ,, . . .. .. . - - .... .. . . ~ -. ~ . ., ` . ~ , .~. .,.. `. - . .. - .
,. ..... ... . - .. ~ . ,.,. . -. .. ` .
` . , - ` ~ - . . . - ,. . - . . - .
- , -. .... . . . . .
, ., .. ,~ . . . .
W~92/16189 ~' P~/,US91~0 From the above it is seen that dopa quinone, leuco dopachrome, dopachrome, DHICA, 5,6-dihydroxyindole, indole-5,6-quinone, and melanochrome are all derivatives of dopa.
Dopa itself is a derivative of tyrosine, so the above compounds are also derivatives of tyrosine (see Scheme II).
Scheme I shows that dopachrome can give rise to 5,6-dihydroxyindole in a spontaneous non-enzymatic reaction, or it can give rise to DHICA in an enzymatically-catalyzed reaction. Copachrome can also give rise to DHICA in a metal-catalyzed reaction (not shown). The enzyme which catalyzes dopachrome to DHICA is named dopachrome isomerase and may indeed be the enzyme responsible for soluble melanin formation. The enzyme may also be a part of a complex comprising tyrosinase, dopachrome isomerase, glycoprotein 75, MSH receptor and other unknown proteins.
The above described enzymes are described in the following papers:
tyrosinase: Ann Korner and John Pawelek, "Mammalian Tyrosinase Catalyzes Three Reactions in the Biosynthesis of Melanin", Science, 217:1163-1165, 1982;
dopachrome isomerase: John Pawelek, `'Dopachrome Conversion Factor Functions as an Isomerase", Biochemical and Bio~hvsical Research Communications, 166:1328-1333, 1990, glycoprotein 75: Timothy M. Thomson, M. Jules Mattes, Linda Roux, Lloyd Old and Kenneth O. Lloyd, "Pigmentation-associated Glycoprotein of Human Melanomas and Melanocytes:
Definition with a Mouse Monoclonal Antibody", J. Invest.
Derm., 85:169-174, 1985;
MSH receptor: Seth J. Orlow, Sara Hotchkiss, and John M.
Pawelek, "Internal Binding Sites for MSH: Analyses in Wild-Type and Variant Cloudman Melanoma Cells", J. Cellular Phvsioloav, 142:129-136, 1990.
The enzyme may also include dopachrome isomerase and one or more of glycoprotein 75, MSH receptor and 81)BSTITi~TE SHEET
~.......... . .
... - . . .
' - - -:
WO9~/161X9 PCT/~'S91/0~ ~ ~
~ ) 2 ~ `~ ;' 12 tyrosinase.
The enzyme may take the form of one or more individual enzymes or a complex of enzymes including tyrosinase, dopachrome isomerase, glycoprotein 75, MSH
receptor and one or more additional enzymes which are distinct from the aforesaid four described enzymes, ~ut which are capable of catalyzing the synthesis of soluble melanin.
The soluble melanin according to the present invention can be admixed with a physiologically acceptable carrier to form a composition, which has the uses previously noted.
Physiologically acceptable carriers useful in the practice of the invention are known in the art and non-limiting examples of such carriers include, for controlled release--microcapsules comprising carboxymethylene copolymers; for transdermal release-~acrylamides, and for topical application--cosmetic bases.
In addition, if desired, the composition according ;
to this embodiment comprises at least one additive selected from the group consisting of solvents, fragrances, sunscreening agents, preservatives and chelating agents.
Cosmetic basec useful in the practice of the invention are well known and include lotions, creams, ointments, lipstick, blush, cover-up, foundations and dusting powders. Examples thereof may be found in, e.g., U.S. Pat. Nos. 4,228,151; 4,282,206 and 2,949,403.
In the case that the inventive compositions are used as tinting agents for glass and plastic or as industrial product protecting agents, e.g. for protection against W degradation, the inventive composition will be incorporated into the glass or plastic or industrial product. Simply by virtue of their solu~le nature, the inventive compositions are easily incorporated in the glass Sl~BSTlTUTE SHEET
. . . ... . . . ~ . . . .
. . - , , . -: . . . . . . .
.. . ~
W O 9 2 / 1 6 l 8 9 2 . ~ ~l U S 9 I / 0 34 6~ .
or plastic or industrial product. For such uses the carriers, diluents, or the like, would not have to be physiologically acceptable. Other conventional agents for such uses could also be formulated therewith.
Solvents for use in accordance with the invention include, for example, ethanol, isopropyl alcohol, benzyl alcohol, oils, for example, ground nut oil, distilled and/or deionized water, physiological saline solution and the like.
The specific solvent chosen will depend on the method of application.
It may also be desirable to add a preservative to the inventive compositions if they are to be used for topical applications. The preferred mode of administration of the inventive compositions is topical administration.
Still further, the soluble melanin~of the present invention may be combined with substances that stimulate the pigmentary system under conditions of low levels of W
light.
Preservatives are well known and may be exemplified by methylparaben, "DOWACIL 2000" and propylparaben.
If desired, in order to reduce the acidity or -basicity of the inventive compositions, bases, acids or buffers may be added thereto in accordance with the knowledge of the art.
The concentration of soluble melanin in an aerosol, cream, lotion or other composition is preferably 0.01 mg/ml to 1.0 mg/ml, but not restricted to this concentration range.
Solutions have different colors depending on the concentration of "chromophore" dissolved in them. For example, a deep red solution will appear orange or pink when diluted with more solvent, but no additional chromophore. ~-In the case of the soluble melanin, when it is dissolved at ..... . .
.
, : .. . ..
. . .. . ~ . - ~ .
, , ~ ` ~, , ~ . . . .
. . ~ ~ . ...
.
WO 92/16189 ~ J ! ~) ,j PCI /1 ~S91/03464 a fairly high concentration in water, e.g., 0.5 mg/~l, it appears brown-black in color. When more water is added so that the concentration of the soluble melanin is reduced to, e.g., 0.1 mg/ml, the solution appears golden in color. It is not believed that diluting the material changes any shift in the absorbance spectrum, rather it is believed to be a visual perception.
For the nonenzymatic preparation, the 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihdyroxyindole may be maintained separately, for example, in microspheres, or in separate tubes or containers, until being mixed together on the skin of a mammal, e.g., human.
The soluble melanin can be made to adhere to the skin for several days and be resistant to water and soap simply by mixing the soluble melanin with any commercially available preparation of dihydroxyacetone, e.g., Lancome's Conque le du Sol oil ~. The DHA apparently acts as a cross-linking agent to covalently link the melanin with various factors, e.g., proteins, in the skin. It is likely that other cross-linking agents will achieve the same or better results. ~;
The invention will now be described with reference to the following non-limiting examples.
Exam~le 1: Source of Enzvmes - The enzyme preparation for the synthesis of soluble melanin can be obtained from any biological cells or tissues which have the ability to produce melanin, for -example: -(1) extracts of vertebrate skins from horses, cattle, sheep, pigs, or any other such mammalian source;
extracts of skins of fish, amphibian, reptiles, birds, or any other such vertebrate source;
~3UBSTITUT~ SHE~T
- ~ - - ., -. , . . . :
WO~2/16189 PCT/US91/0~6~
~ ~2~, (2) extracts of any botanical source which has the ability to produce melanin, such as mushrooms, potatoes, bananas, or any other such botanical source;
SOLUBLE MELANIN
CROSS-REFERENCE TO REL~TE~ APPLICATIONS
This application is a continuation-in-part application of application Serial No. 07/603,111, filed October 25, 1990, now pending, which is a continuation-in-part application of application Serial No. 07/525,944, filed May 18, 1990, now pending.
BACKGROUND OF THE INVENTION
Field of the Invention The present invention concerns the synthesis of soluble forms of melanin and their composition, and methods of using such compositions to provide a naturally-appearing tan to mammalian skin and hair and to provide a sun-screen, to treat post-inflammatory hypo- and hyperpigmentation, to tint glass and plastic, and to protect industrial materials against ultraviolet damage.
Back~round Information In biology, melanins are heteropolymers consisting of L-dopa and its enzymatic derivatives. They are ubiquitous in living organisms and are produced throughout the zoological and botanical phyla. In mammalian skin, melanins are produced through enzymatic processes in specialized cells known as "melanocytes". Melanins are the ~-pigments of mammalian skin and hair.
Mammalian melanins are highly insoluble and can be dissolved (solubilized) only through non-physiological treatments such as boiling in strong alkali, or through the use of strong oxidants such as hydrogen peroxide.
Tyrosinase, a key enzyme in the melanin biosynthetic -pathway, can catalyze the formation of melanin in a test , tube using L-tyrosine, L-dopa or 5',6'-dihydroxyindole as substrates, however, the product is an insoluble precipitate as described above. - ~-:
. .
SUBSTITUTE SftEET
... .
:;, . . . - . - i ~.
. -" . . ~.. . - , , " .. . . - - ; ` , ~ .
wo92"6~89 ~n~ PCT/US91/0~6~
Ito, "Reexamination of the Structure of Eumelanin", 8iochimica et BioPhYsica Acta, 883, 155-161, 1986, mentions natural melanin may ~e a polymer of 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid.
Ito, however, does not teach or suggest com~ining these chemicals to form melanin.
Ito and Nicol, "Isolation of Oligimers of 5,6-Dihydroxyindole-2-carboxylic Acid from the Eye of the Catfish", ochemical Journal. 143, 207-217, 1974, mention that oligimers of 5,6-dihydroxyindole-2-carboxylic acid exist in nature, for example in the tapetum lucidum of the sea catfish (Arius felis). Ito and Nicol, however do not teach or suggest that these structures could be used as a form of soluble melanin.
Palumbo, d'Ischia, Misuraca, and Prota, "Effect of metal ions on the rearrangement of dopachrome", Biochimica et BiophYsica Acta, 925, 203-209, 1987, mention that the metal ions Cu2, Ni2, and Co2 are effective in inducing the non-decarboxylative rearrangement of dopachrome at physiological pH values, leading mainly to the formation of 15,6-dihydroxyindole-2-carboxylic acid. They suggest that when considered in the light of the known metal accumulation in pigmented tissues, their results provide a new entry into the regulatory mechanisms involved in the biosynthesis of ~elanin. Palumbo et al, however, do not teach or suggest that such metal ions could be used to affect the color or formation of soluble melanin. Likewise, Leonard, Townsend, and King, "Function of Dopachrome Oxidoreductase and Metal Ions in Dopachrome Conversion in the Eumelanin Pathway",.
Biochemistrv, 27, 6156-6159, 1988, present similar results to those of Palumbo et al regarding metal ions and the formation of 5,6-dihydroxyindole-2-carboxylic acid from dopachrome. Like Palumbo et al, Leonard et al also do not teach or suggest that such metal ions could be used to SUBSTIT~)TE ~i#EEr , .. ~....... . . .
..... . . . .. .. ... . .
. -.. .. .... -,,.. . .: ~, .
W09~/161X~ ~Tl~S~IJO~
affect the color for formation of soluble melanin.
Many reports exist exploring the role of sulfhydryl compounds such as cysteine or glutathione in determining the red or yellow colors in melanin (see review by Pawelek and Korner, "The Biosynthesis of Mammalian Melanin", American Scientist, 70, 136-145, 1982). However these reports do not teach or suggest that said sulfhydryl compounds could be used to influence the colors of soluble melanins.
It would be of commercial value to have forms of melanin which are soluble at physiological pH and temperature. Such melanins could be applied evenly to mammalian skin and hair in appropriate vehicles without any of the caustic side-effects arising from the harsh reagents needed to solubilize precipitated melanins.
Such solubilized melanins could impart a naturally-appearing tan to mammalian skin and hair.
Solubilized melanins would also be effective as sun-screens, since melanins are the chemicals in the s}cin which absorb ultraviolet radiation and thus provide protection from its harmful effects, such as premature skin aging and the occurrence of skin cancers.
Such solubilized melanins would be effective to treat post-inflammatory hypo and hyper-pigmentation due to eczema, acne, trauma, burns and psoriasis. Also, as a cover-up for vitiligo and other disorders of hypopigmentation, soluble melanins would be quite effective.
Since melanins absorb light throughout the ultraviolet and visible spectra, solubilized melanins would also be effective as glass or plastic tinting agents for eye glasses, contact lenses, car windows, house windows, office buildings, etc.
Likewise, by absorbing in the ultraviolet range, solubilized melanins would be effective agents to protect SUBSTITUTE SHEET
. . ., .. ; ~ . :
: :. ' ' - `. ': ' -W092/16189 2 ~ PCT/~Sg1/o~
industrial materials against damage from ultraviolet radiation. By "industrial material" or "industrial product"
is meant, for example, truck and car tires, paints, laminating materials, plastics, synthetic resins, and fabrics, particularly fabrics containing nylon, and like materials or products. It is well known that the rate of deterioration of paints, wood, plastics and rubber is dramatically increased by exposure to ultraviolet radiation.
SUMMARY OF THE INVENTION
It is the object of the present invention to provide solubilized forms of melanin at physiological pH and temperatures.
It is another object of the present invention to provide compositions and methods for applying such melanins to mammalian skin and hair to provide a naturally-appearing tan.
It is another object of the present invention to provide compositions and methods for applying such melanins to mammalian skin and hair to provide a sun-screen.
It is another object of the present invention to provide compositions and methods of applying such melanins to skin to treat hypo- or hyperpigmentation. ;
It is another object of the present invention to provide compositions and methods for applying such melanins to glass and plastic to provide tint.
It is another object of the present invention to -~
provide compositions and methods for applying such melanins to industrial products to provide protection against ultraviolet radiation.
It is another object of the inventio to provide coloring and/or flavoring agents based on soluble melanin for foodstuffs such as coffee, tea, soda, whiskey, liquor, and the like.
SUBSTITUTE SHEET
- . . , .- - .
., . ....... ~ . . j .` . . . . . . . . - . ~ . . .` . . : -W092/161~ , PCT/~'S91/0 h ~.~ v !~ ,.; . i The above objects and other objects, aims, and advantages are satisfied by the present invention. The present invention relates to a melanin that is soluble in aqueous solution, e.g., water or an aqueous buffered solution, at a pH of at least 5 to 9, preferably 6.5 to 7.5, at a temperature of 0 to 100C. The soluble melanin is further characterized by being capable of being filtered through at least a 0.45 micron size filter. The solubility of the melanin is in large part due to the abundance of carboxyl-groups.
The present invention also concerns a method of producing solubilized melanin comprising combining in a reaction mixture dopachrome and one or more enzymes derived from biological cells or tissues which have a pigmentary system. 5,6-dihydroxyindole may be added to the dopachrome and enzyme(s) or dopachrome may be allowed to spontaneously form 5,6-dihydroxyindole before adding the enzyme(s).
Alternatively, the reaction mixture may comprise 5,6- -dihydroxyindole-2-carboxylic acid alone or in a mixture with 5,6-hydroxyindole, in which case enzymes are not necessary and the reaction occurs in the presence of oxygen.
The color of the soluble melanin can be varied between black, brown, red and yellow by altering the contents of the reaction ~ixtures, for example by adding sulfhydryl containing compounds, or various metals such as, but not limited to, Cu2', Ni2', and Co2~ or by altering the pH
of the reaction mixtures.
The basis for the solubility of the melanin is in a large part due to the high degree of carboxyl groups present in the molecule, said carboxyl groups being incorporated as part of the 5,6-dihydroxyindole-2-carboxylic acid precursor. Compounds similar to 5,6-dihydroxyindole-2-carboxylic acid could substitute in providing said carboxyl groups and could therefore also act as precursors to soluble BSTITU, E SHEET
- , ., ~ , . ~ -:
... . . .
, ~ . . . . .
. , . ~: ,.: .-.
W092/l6189 PCT/US91/0 ~ 6 melanin.
~RIEF DESCRIPTION OF T~E DRAWINGS
Fig. 1 depicts a photograph showing the enzymatic formation of soluble melanin according to the invention.
Non-enzymatically formed soluble melanin is similar in composition to that seen in the tubes labelled "DI Complex".
Fig. 2 depicts a graph showing the optical density (O.D.) of soluble melanin according to the invention at wavelengths greater than 300 nm.
The soluble melanin was synthesized non-enzymatically by mixing 5,6-dihydroxyindole (DHI) and 5,6-dihydroxyindole-2-carboxylic acid (DHICA). The closed diamonds represent a fresh, non-incubated mixture of DHI and DHICA where no soluble melanin was present. The open sguares represent the same mixture incubated 18 hours at room temperature in the presence of oxygen during which time soluble melanin was synthesized.
The high absorbance peaking between 310-320nm is characteristic of the presence of DHICA in the melanin. The broad absorbance over the range from 400-600nm is due in the presence of visible color, characteristic of soluble melanin. Shown here are absorbance spectra in the "ultraviolet A" range and higher. Not shown are the strong absorbance spectra of the soluble melanin in the ultraviolet B and C ranges.
Fig. 3 depicts a graph showing the optical density (O.D.) of soluble melanin according to the invention at wavelengths greater than 300 nm. The soluble melanin was synthesized non-enzymatically as in Fig. 2 under either aerobic (closed diamonds) or anaerobic conditions (open square). It can be seen that oxygen increases the amount of absorbance in the 400-600nm range, i.e., the amount of visible color. -~
':
SUBSTITUTE SHEET
...... ~ ... . , .. :
. . . - . .
. - - .. :
. . . . . . .. .,:
W092/16189 ;;. PCT~US91/0~ ~
k i Fig. 4 depicts a graph showing the optical density (O.D.) of soluble melanin according to the invention at wavelengths greater than 300 nm. The melanin was synthesized either non-enzymatically by mixing DHI and DHICA
(closed diamonds) as described in Figs. 2 and 3; or enzymatically by mixing dopachrome isomerase enzyme complex (DI) with dopachrome and DHI (open diamonds), or by mixing DI with only DHI (open squares), or by mixing DI with DHI
plus DHICA (closed squares). The results demonstrate that en7ymatic and non-enzymatic methods for synthesizing soluble melanin yield comparable products. They also demonstrate the necessity of DHICA or a compound similar to DHICA in the reaction mixtures.
Figure 5 depicts a graph showing the optical density of soluble melanin synthesized non-enzymatically at pH 7. The reaction mixtures were comprised of a mixture of DHICA and DHI (closed diamonds) or DHICA alone (open squares). The results demonstrate that at pH 7 more visible melanin (400-600 nm) is synthesized with a mixture of DHI
and DHICA than with DHICA alone.
Figure 6 depicts a graph showing the optical density of soluble melanin synthesized non-enzymatically at pH 8. The reaction mixtures are otherwise the same as those in Figure 5. The results demonstrate that at pH 8, DHICA
alone can serve as an efficient precursor to the formation of soluble melanin and in fact is somewhat superior to a mixture of DHICA and DRI.
Figure 7 depicts a graph showing a pH titration curve as increasing amounts of acetic acid are added to a ;
solution of 2mM soluble melanin.
Figure 8 depicts a graph showing the precipitation of soluble melanin durinq the pH titration shown in Figure 7. For each point, acetic acid was added and the solution was allowed to sit at room temperature before being filtered SUaSTlTUTE SHE~T
,' ` . .. ` ~ . .. . . .
. . . ':.. ~ .
` : `: '. ~ . ~ .
W092/16189 PCT/US91/0~ ~ _ ~0~ 8 through a 0.45 micron filter. The optical density of the filtrate was then determined at 500nm. The soluble melanin begins to precipitate below pH4, i.e. as the pK of the carboxyl groups is reached. The results are consistent with the solubility of the melanin being determined by the number of non-protonated carboxyl groups present in the molecule.
DETAILED DESCRIPTION OF T~E INVENTION
The soluble melanin of the invention remains in aqueous solution, at neutral pH (e.g., pH of 5 to 9, preferably 6,5 to 7.5), for long periods of time, e.g., indefinitely, at temperatures of 0C to 100C, e.g., room temperature. The soluble melanin according to the invention is further characterized by remaining soluble upon freezing/thawing. The inventive soluble melanin is also characterized by being capable of being filtered through at least a 0.45 micron size filter. The solubIe melanin according to the invention can be precipitated below pH4.
Following synthesis, the soluble melanin cannot be dialyzed through a semi-permeable membrane which allows the passage of molecules having less than a molecular weight of approximately lO,OOO. Therefore the soluble melanin according to the invention is of a molecular weight greater than lO,OOO, however, this is not an essential characteristic for its usefulness. The soluble melanin can be lyophilized to a dry powder form and then reconstituted -to its soluble form with distilled water or suita~le aqueous solvents, e.g., sodium phosphate O.lM or sodium chloride O.lM. It can also be reconstituted in organic solvents such as butanol or 2-butoxyethanol.
The soluble melanin according to the invention can be prepared non-enzymatically (synthetically) or e~zymatically.
The enzymatic preparation according to the invention comprises combining in a reaction mixture a SUBSTITUTE SHEET
. " ' .. , - ' . . ... . . . - .
. `
W~42/16~84 ? ~ '~ `pç~y;u$9l/o346q , V
substrate, i.e., dopachrome, and one or more enzymes derived from biological cells or tissues which contain a pigmentary system and more particularly have the ability to produce melanin.
In the non-enzymatic preparation according ~o the invention, the reaction mixture comprises as a substrate 5,6-dihydroxyindole-2-carboxylic acid (DHICA) alone or a mixture of DHICA and 5,6-dihydroxyindole. Suitable analogs of DHICA, i.e. similar structures containing carboxyl groups, maybe substituted in the reaction. The enzymatic or nonenzymatic reaction mixtures may still further comprise as a substrate indole-5,6-quinone and/or melanochrome. Metal ions and sulfhydryl-containing compounds may be included.
The individual components of the sùbstrate, be it one component, i.e., dopachrome, as in the enzymatic preparation, or more than one component as in the nonenzymatic preparation, preferably will be in an amount of .01 to 5.0 millimolar, but not necessarily limited to this concentration range. Stated otherwise, when more than one component is used, the components, i.e., a mixture of 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid, will preferably be in equal proportions or near to equal proportions.
The combining of substrate and enzymes or substrates in the reaction mixture is preferably conducted at a temperature of 15C to 37~C.
It is preferred in both the enzymatic and nonenzymatic preparation that oxygen, e.g., air or pure oxygen, be present. This is especially true for the nonenzymatic preparations.
Structural formulas and the relationship among some of the above described compounds are depicted as follows:
S~JÇ~T~TUTE SI~EEi~
' . ' ' ` .
' , ' ' ' WO 92/1618~ ') Pcr/US9l/0346 Schen~e "~/ , " , .
~ S A ~ ~ t ~; S ~ C ~
: ~ o o ~ o c ll ro rl ~ J ~
Ii^,/ ; ~' :, " ~ "~
5,6~aln~cro-~UIraolc ~,G-al~ aro~ c~
~Olil) ~cheme II
~IJ~ CCO' ~< .. _ `` -'' -;. ~ ~-~cuco Oooocl\rcmc ~Ci~crilrcmr , ~~coo' ~) tl h ~ / ~ X _ ~,, \ . / )-'^ ~`- ' D^~c Ouinonc ~~
N 1~'\.' ~ ~ ~ ~ i i~ ~, c r ^ x , ~r_S r.~S~ I, \
,coc~
-;In~cro:yio~i cn~lolo:iin^ = r~
_ ,, \ ~, , _ .
~ osincse \ \ ~
~,><~,!~COOII Mci"~
o~
~,~OSir1r : .
SUBSTITUTE SHEET
... , . ,, . . .. .. . - - .... .. . . ~ -. ~ . ., ` . ~ , .~. .,.. `. - . .. - .
,. ..... ... . - .. ~ . ,.,. . -. .. ` .
` . , - ` ~ - . . . - ,. . - . . - .
- , -. .... . . . . .
, ., .. ,~ . . . .
W~92/16189 ~' P~/,US91~0 From the above it is seen that dopa quinone, leuco dopachrome, dopachrome, DHICA, 5,6-dihydroxyindole, indole-5,6-quinone, and melanochrome are all derivatives of dopa.
Dopa itself is a derivative of tyrosine, so the above compounds are also derivatives of tyrosine (see Scheme II).
Scheme I shows that dopachrome can give rise to 5,6-dihydroxyindole in a spontaneous non-enzymatic reaction, or it can give rise to DHICA in an enzymatically-catalyzed reaction. Copachrome can also give rise to DHICA in a metal-catalyzed reaction (not shown). The enzyme which catalyzes dopachrome to DHICA is named dopachrome isomerase and may indeed be the enzyme responsible for soluble melanin formation. The enzyme may also be a part of a complex comprising tyrosinase, dopachrome isomerase, glycoprotein 75, MSH receptor and other unknown proteins.
The above described enzymes are described in the following papers:
tyrosinase: Ann Korner and John Pawelek, "Mammalian Tyrosinase Catalyzes Three Reactions in the Biosynthesis of Melanin", Science, 217:1163-1165, 1982;
dopachrome isomerase: John Pawelek, `'Dopachrome Conversion Factor Functions as an Isomerase", Biochemical and Bio~hvsical Research Communications, 166:1328-1333, 1990, glycoprotein 75: Timothy M. Thomson, M. Jules Mattes, Linda Roux, Lloyd Old and Kenneth O. Lloyd, "Pigmentation-associated Glycoprotein of Human Melanomas and Melanocytes:
Definition with a Mouse Monoclonal Antibody", J. Invest.
Derm., 85:169-174, 1985;
MSH receptor: Seth J. Orlow, Sara Hotchkiss, and John M.
Pawelek, "Internal Binding Sites for MSH: Analyses in Wild-Type and Variant Cloudman Melanoma Cells", J. Cellular Phvsioloav, 142:129-136, 1990.
The enzyme may also include dopachrome isomerase and one or more of glycoprotein 75, MSH receptor and 81)BSTITi~TE SHEET
~.......... . .
... - . . .
' - - -:
WO9~/161X9 PCT/~'S91/0~ ~ ~
~ ) 2 ~ `~ ;' 12 tyrosinase.
The enzyme may take the form of one or more individual enzymes or a complex of enzymes including tyrosinase, dopachrome isomerase, glycoprotein 75, MSH
receptor and one or more additional enzymes which are distinct from the aforesaid four described enzymes, ~ut which are capable of catalyzing the synthesis of soluble melanin.
The soluble melanin according to the present invention can be admixed with a physiologically acceptable carrier to form a composition, which has the uses previously noted.
Physiologically acceptable carriers useful in the practice of the invention are known in the art and non-limiting examples of such carriers include, for controlled release--microcapsules comprising carboxymethylene copolymers; for transdermal release-~acrylamides, and for topical application--cosmetic bases.
In addition, if desired, the composition according ;
to this embodiment comprises at least one additive selected from the group consisting of solvents, fragrances, sunscreening agents, preservatives and chelating agents.
Cosmetic basec useful in the practice of the invention are well known and include lotions, creams, ointments, lipstick, blush, cover-up, foundations and dusting powders. Examples thereof may be found in, e.g., U.S. Pat. Nos. 4,228,151; 4,282,206 and 2,949,403.
In the case that the inventive compositions are used as tinting agents for glass and plastic or as industrial product protecting agents, e.g. for protection against W degradation, the inventive composition will be incorporated into the glass or plastic or industrial product. Simply by virtue of their solu~le nature, the inventive compositions are easily incorporated in the glass Sl~BSTlTUTE SHEET
. . . ... . . . ~ . . . .
. . - , , . -: . . . . . . .
.. . ~
W O 9 2 / 1 6 l 8 9 2 . ~ ~l U S 9 I / 0 34 6~ .
or plastic or industrial product. For such uses the carriers, diluents, or the like, would not have to be physiologically acceptable. Other conventional agents for such uses could also be formulated therewith.
Solvents for use in accordance with the invention include, for example, ethanol, isopropyl alcohol, benzyl alcohol, oils, for example, ground nut oil, distilled and/or deionized water, physiological saline solution and the like.
The specific solvent chosen will depend on the method of application.
It may also be desirable to add a preservative to the inventive compositions if they are to be used for topical applications. The preferred mode of administration of the inventive compositions is topical administration.
Still further, the soluble melanin~of the present invention may be combined with substances that stimulate the pigmentary system under conditions of low levels of W
light.
Preservatives are well known and may be exemplified by methylparaben, "DOWACIL 2000" and propylparaben.
If desired, in order to reduce the acidity or -basicity of the inventive compositions, bases, acids or buffers may be added thereto in accordance with the knowledge of the art.
The concentration of soluble melanin in an aerosol, cream, lotion or other composition is preferably 0.01 mg/ml to 1.0 mg/ml, but not restricted to this concentration range.
Solutions have different colors depending on the concentration of "chromophore" dissolved in them. For example, a deep red solution will appear orange or pink when diluted with more solvent, but no additional chromophore. ~-In the case of the soluble melanin, when it is dissolved at ..... . .
.
, : .. . ..
. . .. . ~ . - ~ .
, , ~ ` ~, , ~ . . . .
. . ~ ~ . ...
.
WO 92/16189 ~ J ! ~) ,j PCI /1 ~S91/03464 a fairly high concentration in water, e.g., 0.5 mg/~l, it appears brown-black in color. When more water is added so that the concentration of the soluble melanin is reduced to, e.g., 0.1 mg/ml, the solution appears golden in color. It is not believed that diluting the material changes any shift in the absorbance spectrum, rather it is believed to be a visual perception.
For the nonenzymatic preparation, the 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihdyroxyindole may be maintained separately, for example, in microspheres, or in separate tubes or containers, until being mixed together on the skin of a mammal, e.g., human.
The soluble melanin can be made to adhere to the skin for several days and be resistant to water and soap simply by mixing the soluble melanin with any commercially available preparation of dihydroxyacetone, e.g., Lancome's Conque le du Sol oil ~. The DHA apparently acts as a cross-linking agent to covalently link the melanin with various factors, e.g., proteins, in the skin. It is likely that other cross-linking agents will achieve the same or better results. ~;
The invention will now be described with reference to the following non-limiting examples.
Exam~le 1: Source of Enzvmes - The enzyme preparation for the synthesis of soluble melanin can be obtained from any biological cells or tissues which have the ability to produce melanin, for -example: -(1) extracts of vertebrate skins from horses, cattle, sheep, pigs, or any other such mammalian source;
extracts of skins of fish, amphibian, reptiles, birds, or any other such vertebrate source;
~3UBSTITUT~ SHE~T
- ~ - - ., -. , . . . :
WO~2/16189 PCT/US91/0~6~
~ ~2~, (2) extracts of any botanical source which has the ability to produce melanin, such as mushrooms, potatoes, bananas, or any other such botanical source;
(3) extracts of invertebrate organisms such as worms, arthropods, or any such invertebrate source which has the ability to produce melanin;
(4) extracts of any single-cell organisms which have the ability to produce melanin, but which do not necessarily fall into a category of zoological or botanical, such as bacteria and protozoans;
(5) extracts of any organisms in which genes for enzymes producing soluble melanin have been genetically cloned; and (6) culture media of any organisms or cells which secrete enzymes for producing soluble melanin -such organisms or cells may or may not express cloned genes for the enzymes.
Furthermore, the source of biological material for the isolation of enzymes to produce soluble melanin does not necessarily have to be actively synthesizing melanin in vivo. A pigmentary system is defined as all or part of a group of enzymes which can recognize as their substrates precursors and/or intermediates in the melanin biosynthetic pathway. Some biological sources contain a pigmentary ~ -system, but do not synthesize melanin, however, extracts `~
derived from them can produce soluble melanin. These biological systems, in. their living state, are referred to as "amelanotic", or "non-pigmented". Many albino organisms fall into this category, i.e., they possess an incomplete or inhibited pigmentary system and do not ma~e melanin n vivo, however, extracts from some albino organisms contain enzymes that can produce soluble melanin. Such organisms are also potential sources of enzymes for the production of soluble SUBSTITUTE SHI~
. :. -, . ~ : . : - - .
. . : .; ~ , - . . ;
~ . . . ~ , . . . .
i. . - - .- , .. , ~- ., .-- - - ` ,-. , ,... - .... -W092/16~ 16 PCT/US91/0 melanin.
ExamPle 2: Pre~aration of Enzvmes The enzymes for production of soluble melanin can be isolated from an extract of an appropriate biological source, or, from the culture media should the enzymes be secreted into the media by the source (see Example l).
~xtracts are prepared by lysing the cells of the biological source through procedures such as homogenization (e.g., in a common kitchen "blender", in appropriate glass, metal, or plastic tissue homogenizers); such as freeze-thawing in a hypotonic solution such as water; or by any means which disrupt the cellular wall or plasma membrane of the biological source. In cases where _he enzymes for producing melanin are themselves insoluble (e.g., in a particulate form within the cells), it may be necessary to lyse the cells in the presence of a non-ionic detergent such as "TRITON X-l~0", "CHAPS", or "TWEEN 80", or an organic solvent such as acetone or ethanol, or any other solvents which solubilize the enzymes, without destroying their ability to~ produce soluble melanin.
The following procedures may be useful, but are not mandatory for the preparation:
Extracts containing the enzymes in a soluble form can be clarified by filtration through such material as gauze or filter paper; or by centrifugation; or by "settling" through the use of natural gravitational force.
Extracts can be further clarified by mixing them with calcium phosphate (also known as "hydroxylapatite") which is itself insoluble, but which attaches to many molecular structures in cells, but does not attach to the enzymes for preparation of soluble melanin. The calcium phosphate and its attached molecules can be removed from the extract by filtration, centrifugation, or gravitational SU~STIT~ SHEET
. . , ~ - -, ` ..
~: ; . :
... ... ..
WO92/16189 PCT/US91/0~6~
"~
l7 )~ ~J U tJ
settling as described above. Although calcium phosphate is useful in this regard, the procedure is not restricted to the use of this agent only. Any insoluble compound which attaches to molecular structures other than the enzymes in question and does not destroy the activity of the enzymes can be employed.
Extracts can be further clarified by mixing them with an anion exchange agent such as diethylaminoethyl cellulose. At conditions around neutral pH (e.g., pH 6.5-7.5) and low buffer concentration (e.g., 5-lO millimolar sodium phosphate), the enzymes or production of soluble melanin will attach to such an anion exchange agent, while many other molecular structures will not. The enzymes in question can then be eluted from the anion exchange agent by increasing the salt concentration (e.g., by adding 0.4 molar sodium chloride, or by using a gradient of sodium chloride from 0 molar to 0.4 molar). Although diethylaminoethyl cellulose, sodium phosphate, and sodium chloride are useful in this regard, the procedure is not restricted to the use of these agents only. Any anion exchange resin, buffer, or salt which does not destroy the activity of the enzymes in question can be employed. The principle is the same. - -Extracts can be further clarified by mixing them with an agent which attaches to glycoproteins, such as wheat germ lectin-sepharose. In mammalian cells, the enzymes in -`
question are glycoproteins and therefore attach to such lectins, while many other molecular structures do not. The enzy~es in question can then be eluted from the lectin by mixing with an appropriate sugar such a N-acetylglucose-amine, which causes a displacement of the enzymes from the lectin. Although wheat germ lectin-sepharose, and N-acetyl-glucoseamine are useful in this regard, the procedure is not restriGted to the use of these agents only. Any appropriate lectin or sugar which does not destroy the activity of the ~iU~TlTUTE SHEET
- . - -. , ; ~ . - , - , Wo92/16189 )r~ 18 PCT/US91/0~64 enzymes in question c~n be employed. The principle is the same.
Extracts can be further clarified by applying them to columns containing molecular sieves such as Sephadex columns, or high pressure liquid chromatography columns containing molecular sieves. The enzymes in question can be eluted from such columns with non-destroying buffers according to their molecular weights and can be thereby separated from other molecular structures with differing molecular weights. Although Sephadex columns and various HPLC resins are useful molecular sieves, the procedure is not restricted to the use of these agents only. Any appropriate method for separation of molecules according to their molecular weights which does not destroy the activity of the enzymes in question can be employed. When each of the above procedures is carried out in the sequence listed, a preparation is obtained which contains the following:
tyrosinase, dopachrome isomerase, a protein designated "glycoprotein 75" or "gp75", which exhibits catalase activity, and a protein designated "MSH receptor". That is, these four known proteins co-purify through the above procedures. Analyses by polyacrylamide gel electrophoresis indicate that there may be ten or more proteins in total.
It is not presently known which protein or combination thereof catalyzes the synthesis of soluble melanin, although the synthesis can occur in the presence of phenylthiourea, a potent inhibitor of tyrosinase, suggesting that tyrosinase may not be necessary.
Exam~le 3: Enzvmatic Svnthesis of Soluble Melanin Soluble melanin is prepared enzymatically by mixing the enzymes, isolated and purified as described above, with a solution containing dopachrome and 5,6- -dihydroxyindole. The enzymes and the substrates are allowed SUBSTITUTE S~IEET
:. .. . : .
.. - . . - . . . , W~92/16189 2 ~ 6Ç~
to incubate in a non-destroying buffer (e.g., O.l molar sodium phosphate, pH 6.5-7.S) at ambient temperature or any suitable non-destroying temperature which allows for the reaction to occur (e.g., 15-37-C), until soluble melanin begin to appear (e.g., 3-6 hours). The reaction can be monitored visually or with the use of a spectrophotometer set in the visual spectrum (e.g., 400 millimicrons). When the reaction has reached completion, the salts from the buffer can be removed by dialysis and the soluble melanin can be stored at room temperature, frozen, or as a crystal or powder obtained through such procedures as natural evaporation or lyophilization. It is useful, but not mandatory, to enzymatically synthesize soluble melanin in the presence of a tyrosinase inhibitor such as phenylthiourea, because tyrosinase, which is occasionally present in the enzyme preparation, can cause the formation of insoluble melanin. Although phenylthiourea is a useful tyrosinase inhibitor because it does not inhibit or destroy the enzymes in question, the procedure is not restricted to phenylthiourea and any such tyrosinase inhibitor can be employed.
Soluble melanin prepared by the above procedure is golden-brown in color and absorbs widely throughout the ultraviolet and visible spectra (e.g., 220 to 700 millimicrons). The color can vary from brown-black in very concentrated solutions, to golden in more dilute solutions.
The addition of sulfhydryl-containing compounds such as cysteine or glutathione can impart a reddish color to the soluble melanin.
Fig. l depicts the enzymatic formation of soluble melanin. The contents of the three tubes on the right were filtered through a 0.4S micron filter, otherwise they were identical in composition to the contents of the three tubes on the left. Considering the three tubes on the left:
S~JBSTIl-~TE S~IEET
.. . ., .~ , ` :
.
` ` :. .: . ' , ' : . ` ` .. ` ;. . `
`; :. . ` `
,: ~ ~. . - .. ` .
WO92/16189 PCT/US91/0~64 ~ j,j 20 l) The far left-hand tube contained a mixture of dopachrome, dopa and 5,6-dihydroxyindole. It also contained the buffer used to dissolve the enzymes (sodium phosphate 5mM, pH 6.8, containing 20% glycerol vol/vol), but the enzymes themselves were not added.
2) The second tube from the left contained the same mixture as in the left-hand tube, but in addition it contained the enzymes dissolved in their buffer. The enzymes are referred to as "DI Complex".
3) The third tube from the left was identical to the middle tube, but also contained trypsin, a potent proteolytic enzyme, at a concentration of 0.5 mg/ml.
The three tubes on the left were incubated at room temperature for 6 hours before half their contents were removed and filtered as described above into the three right-hand tubes.
It can be seen that with buffer only, all the black melanin which formed was trapped on the filter, i.e., insoluble. When the DI Complex was added, the golden-brown melanin was completely filterable, i.e., soluble. When trypsin was present, no soluble melanin was formed, indicating that the soluble melanin production was catalyzed by a protein (enzyme). Melanin prepared non-enzymatically are similar in appearance to those seen in the tubes labelled "DI Complex".
The soluble melanin provided in Example 3 have the following characteristics: -(l) are greater than molecular weight lO,000, ~-(2) are stable to boiling, -(3) are stable to freezing, (4) can be filtered through a filter at least as small as 0.45 microns, (5) are soluble in water at a pH range of at least 6.5 to 7.5 at temperatures from 0 to 100C, SlJBST~T~TE SHEET.
.. .. . . . . .
.... ~. . , .'.......... `: . .. ~.
. , . ~ . : ~, , ~
- ... . ., . - . . . ~
~ . . : , . : . . ,.. .. : :-. . - .. . . . . : , WO92~l6l89 ,~r~ ?~;P~US91/0~6 (6) can be precipitated below pH 4, (7) can be lyophilized to a crystal/powder ~orm which can be redissolved in water, (8) vary from brown-black to golden in color dependlng on concentration, (9) absorb throughout the ultraviolet and visible spectra and (10) can be prepared in red and yellow forms with the addition of sulfhydryl-containing compounds and various metal ions.
ExamDle 4: Non-Enzvmatic Svnthesis of Soluble Melanin Soluble melanin can be prepared in a nonenzymatic reaction by mixing 5,6-dihydroxyindole-2-carboxylic acid (DHICA) and 5,6-hydroxyindole (DHI) in the presence of oxygen in a non-destroying buffer (e.g., 0.1 molar sodium phosphate, pH 6.5 to 7.5) or by incubating DHICA alone at ambient temperature of any suitable non-destroying temperature which allows the reaction to occur (e.g., 15 to 37'C), until soluble melanin begins to appear (e.g., 3 to 6 hours). The soluble melanin thus formed is indistinguishable from that which is formed enzymatically as described in Example 3.
The difference between enzymatic and non-enzymatic synthesis of soluble melanin is that in the enzymatic synthesis, 5,6-dihydroxyindole-2-carboxyl acid is produced from dopachrome by the enzyme dopachrome isomerase, and 5,6-dihydroxyindole is prQduced spontaneously from dopachrome, while in the non-enzymatic synthesis, 5,6-dihydroxyindole-2-carboxylic acid (DHICA) and 5,6-dihydroxyindole are mixed directly to form soluble melanin or DHICA is incubated alone. In both the enzymatic and non-enzymatic procedures, the reaction is greatly enhanced by the presence of oxygen.
SU BSTITUTE SHEET
.
. ~ . . . .. . . -: -~ ~ - ., .' . ~.
~, WO92/16189 PCT/~'S91/0~64 ~ owever, once DHICA dissolves, it begins to spontaneously convert to soluble melanin. If it is to be used on the skin, then it should be in an oxygen-free vehicle. Accordingly, when not in use, store DHICA in a freezer, weighing out small amounts at time of use. DHICA
is much more stable at pH 6 than p~ 8.
~xam~le 5: SpectroDhotometric Ouantitation of Soluble Melanin Melanin was synthesized using a mixture of L-dopa, dopachrome, dihydroxyindole, and dihydroxyindole-2-carboxylic acid at concentrations of approximately 0.4 mg/ml dissolved in sodium phosphate, 0.lM, pH 6.8. The "DI
Complex" enzymes purified approximately 2,000 fold from 0.5 grams mouse melanoma tissue (see Example 3) were dissolved in buffer (sodium phosphate,`5 mM, pH 6.8) and incubated in a 4 ml reaction mix with the above substrates at room temperature for 5 hours. The control reaction had buffer only, with no enzymes added. In both reactions, melanin formation occurred, but when the enzymes were present, the melanin could be filtered through a 0.45 micron filter, whereas in the presence of buffer only, the melanin was insoluble and could not be filtered. Solutions were diluted 50 fold before measuring the optical density. A
photographic representation of this experiment is seen in Fig. l.
Figs. 2 to 4 show the optical spectrum of soluble melanin according to the present invention. In Figs. 2 to 4, the melanin exhibited a peak optical density (O.D.) at a wavelength of 310-320 nm. ~he spectra and O.D. were the same after the melanin had incubated under sterile conditions for 2 months at room temperature (20C), and whether or not the melanin was dialyzed or filtered through a 0.45 micron filter.
SlJBST~TUTE SHEET -~
,. . ..... , ... ~ .. : . . , . . . .. - ...... , , . :
,. . . . , . .
WO92/16189 PCT/~'S91/0~64 23 ~"ui,~
Note in Fig. 4 that relatively little soluble melanin is made when D~I plus DI are mixed together in the absence of any other added substrates. Note also, when DHI
plus DHICA are mixed together they make as much soluble melanin as when they are mixed additionally with DI, i.e., DI is not necessary in this case. Finally, note that a mixture of dopachrome and DHI in the absence of DI results in an insoluble precipitate (not shown here), but in the presence of DI results in the synthesis of soluble melanin.
This is because DI converts dopachrome to DHICA which then in turn combines with DHI in the presence of oxygen to form soluble melanin. In the absence of DI, dopachrome spontaneously converts to DHI and a precipitate (insoluble melanin) forms (see Scheme I hereinabove).
Figures 5 through 8 are described hereinabove.
Table l: S~ectro~hotometric Ouantitation of Soluble Melanin Optical DensitY at Wavelenath 320 nm Synthetic Route Before Filtration After Filtration Buffer only l.22 .024 (no enzymes added) Enzymes added 0.982 0.966 ExamDle 6: Transdermal Release Composition An admixture is prepared comprising the following:
.
Parts b wei ht Y q -.
Acrylamide copolymer 20 (e.g., "polytrap FLME 203") soluble melanin, as prepared according to Examples 3 or 4 5 ~JE3~TITUTE SHEET
. :
' ` -..................... . ~ . . . .
W092/16189 .~ PCT/US91/0 Alcohol 74.9 and a fraarance 0.1 The above mixture is applied to the skin, once a day, preferably in the morning, for two to four weeks.
;~ ','' ~,-''' . , ~
- . .:
~ ~ SUBST~TUTE SHEET :
W092/16189 ~ PC~/US91/0~ ~
~ ;J, ,~ J ~
ExamDle 7: Tanninq Oil A. An admixture is prepared by adding in the order indicated:
_ _ Parts by weiaht decylolcate 25.0 isopropyl myristate 15.0 and propylene glycol dicaprylate/
dicaprate 5.0 mineral oil 54.85 B. An admixture is prepared by adding 0.01 pbw soluble melanin, e.g., as prepared as described in Example 3 or 4, to 0.01 pbw of "SOLERTAN PB-10" (a poly(propylene glycol) lanolin ether).
C. The admixture of part B is added to the admixture of part A and the resultant admixture is mixed until homogeneous.
D. The composition of part C is applied to the skin once or twice daily for two to four weeks.
SIJBSTITUTE SHEET ~;
` . . ~ , .: : , ::., . ,,. -.
. " .. . . . -;
~J~ 26 Example 8: Suntannina Lotion An admixture was prepared containing the following:
Parts by weiaht ICI G-1800 5.0 (e.g., poly[oxyethylene]21 stearyl ether) isopropyl myristate lO.o preservative O.l stearyl alcohol 2.0 2-hydroxy-3,3,5-trimethylhexyl 8.0 t ester of benzoic acid butylated hvdroxvanisole _ 0.05 The above mixture is heated to 70C and 60 parts by weight of water, preheated to 70C is added thereto. the resultant mixture is stirred and allowed to cool to room temperature.
To the above mixture is then added a 1% citric acid solution, QS, to achieve a pH of 5.0 after which 0.01 parts by weight of a soluble melanin, for example, as prepared according to Example 3 or Example 4, is added, as well as sufficient deionized water to yield lO0 parts by weight of lotion. ~ `
The above lotion is applied to the skin one-half (l/2) hour prior to exposure to the sun. After swimming, sweating or toweling, as well as after each hour of exposure, the lotion is reapplied.
The soluble melanin of the present invention can - ~;
also be incorporated into foodstuffs as a coloring and/or flavoring agent, e.g. into coffee, tea, soda, beer, liquor, ice cream, frozen yogurt, barbecued potato chips, and the like. The amount added of course depends on the magnitude S~BsTlTll~E ~EET
...... .. .... .. . .... ... .... .
W~'~2/16189 PCT/US91/0~64 of the effect desired, but for liquids (beverages) it would be in the range of l-lO00 mg/liter and for solids (foodstuffs) it would be in the range of l-lO00 mg/kg. The amounts added would not be limited to these ranges.
It will be appreciated that the instant specification is set forth by way of illustration and not limitation, and that various modification and changes may be made without departing from the spirit and scope of the present invention.
SUBSTITUTE SHEET
., .. .. ~ - , .
` - ~ . .
. .
, ~ , - , ~,. . . . ~.
Furthermore, the source of biological material for the isolation of enzymes to produce soluble melanin does not necessarily have to be actively synthesizing melanin in vivo. A pigmentary system is defined as all or part of a group of enzymes which can recognize as their substrates precursors and/or intermediates in the melanin biosynthetic pathway. Some biological sources contain a pigmentary ~ -system, but do not synthesize melanin, however, extracts `~
derived from them can produce soluble melanin. These biological systems, in. their living state, are referred to as "amelanotic", or "non-pigmented". Many albino organisms fall into this category, i.e., they possess an incomplete or inhibited pigmentary system and do not ma~e melanin n vivo, however, extracts from some albino organisms contain enzymes that can produce soluble melanin. Such organisms are also potential sources of enzymes for the production of soluble SUBSTITUTE SHI~
. :. -, . ~ : . : - - .
. . : .; ~ , - . . ;
~ . . . ~ , . . . .
i. . - - .- , .. , ~- ., .-- - - ` ,-. , ,... - .... -W092/16~ 16 PCT/US91/0 melanin.
ExamPle 2: Pre~aration of Enzvmes The enzymes for production of soluble melanin can be isolated from an extract of an appropriate biological source, or, from the culture media should the enzymes be secreted into the media by the source (see Example l).
~xtracts are prepared by lysing the cells of the biological source through procedures such as homogenization (e.g., in a common kitchen "blender", in appropriate glass, metal, or plastic tissue homogenizers); such as freeze-thawing in a hypotonic solution such as water; or by any means which disrupt the cellular wall or plasma membrane of the biological source. In cases where _he enzymes for producing melanin are themselves insoluble (e.g., in a particulate form within the cells), it may be necessary to lyse the cells in the presence of a non-ionic detergent such as "TRITON X-l~0", "CHAPS", or "TWEEN 80", or an organic solvent such as acetone or ethanol, or any other solvents which solubilize the enzymes, without destroying their ability to~ produce soluble melanin.
The following procedures may be useful, but are not mandatory for the preparation:
Extracts containing the enzymes in a soluble form can be clarified by filtration through such material as gauze or filter paper; or by centrifugation; or by "settling" through the use of natural gravitational force.
Extracts can be further clarified by mixing them with calcium phosphate (also known as "hydroxylapatite") which is itself insoluble, but which attaches to many molecular structures in cells, but does not attach to the enzymes for preparation of soluble melanin. The calcium phosphate and its attached molecules can be removed from the extract by filtration, centrifugation, or gravitational SU~STIT~ SHEET
. . , ~ - -, ` ..
~: ; . :
... ... ..
WO92/16189 PCT/US91/0~6~
"~
l7 )~ ~J U tJ
settling as described above. Although calcium phosphate is useful in this regard, the procedure is not restricted to the use of this agent only. Any insoluble compound which attaches to molecular structures other than the enzymes in question and does not destroy the activity of the enzymes can be employed.
Extracts can be further clarified by mixing them with an anion exchange agent such as diethylaminoethyl cellulose. At conditions around neutral pH (e.g., pH 6.5-7.5) and low buffer concentration (e.g., 5-lO millimolar sodium phosphate), the enzymes or production of soluble melanin will attach to such an anion exchange agent, while many other molecular structures will not. The enzymes in question can then be eluted from the anion exchange agent by increasing the salt concentration (e.g., by adding 0.4 molar sodium chloride, or by using a gradient of sodium chloride from 0 molar to 0.4 molar). Although diethylaminoethyl cellulose, sodium phosphate, and sodium chloride are useful in this regard, the procedure is not restricted to the use of these agents only. Any anion exchange resin, buffer, or salt which does not destroy the activity of the enzymes in question can be employed. The principle is the same. - -Extracts can be further clarified by mixing them with an agent which attaches to glycoproteins, such as wheat germ lectin-sepharose. In mammalian cells, the enzymes in -`
question are glycoproteins and therefore attach to such lectins, while many other molecular structures do not. The enzy~es in question can then be eluted from the lectin by mixing with an appropriate sugar such a N-acetylglucose-amine, which causes a displacement of the enzymes from the lectin. Although wheat germ lectin-sepharose, and N-acetyl-glucoseamine are useful in this regard, the procedure is not restriGted to the use of these agents only. Any appropriate lectin or sugar which does not destroy the activity of the ~iU~TlTUTE SHEET
- . - -. , ; ~ . - , - , Wo92/16189 )r~ 18 PCT/US91/0~64 enzymes in question c~n be employed. The principle is the same.
Extracts can be further clarified by applying them to columns containing molecular sieves such as Sephadex columns, or high pressure liquid chromatography columns containing molecular sieves. The enzymes in question can be eluted from such columns with non-destroying buffers according to their molecular weights and can be thereby separated from other molecular structures with differing molecular weights. Although Sephadex columns and various HPLC resins are useful molecular sieves, the procedure is not restricted to the use of these agents only. Any appropriate method for separation of molecules according to their molecular weights which does not destroy the activity of the enzymes in question can be employed. When each of the above procedures is carried out in the sequence listed, a preparation is obtained which contains the following:
tyrosinase, dopachrome isomerase, a protein designated "glycoprotein 75" or "gp75", which exhibits catalase activity, and a protein designated "MSH receptor". That is, these four known proteins co-purify through the above procedures. Analyses by polyacrylamide gel electrophoresis indicate that there may be ten or more proteins in total.
It is not presently known which protein or combination thereof catalyzes the synthesis of soluble melanin, although the synthesis can occur in the presence of phenylthiourea, a potent inhibitor of tyrosinase, suggesting that tyrosinase may not be necessary.
Exam~le 3: Enzvmatic Svnthesis of Soluble Melanin Soluble melanin is prepared enzymatically by mixing the enzymes, isolated and purified as described above, with a solution containing dopachrome and 5,6- -dihydroxyindole. The enzymes and the substrates are allowed SUBSTITUTE S~IEET
:. .. . : .
.. - . . - . . . , W~92/16189 2 ~ 6Ç~
to incubate in a non-destroying buffer (e.g., O.l molar sodium phosphate, pH 6.5-7.S) at ambient temperature or any suitable non-destroying temperature which allows for the reaction to occur (e.g., 15-37-C), until soluble melanin begin to appear (e.g., 3-6 hours). The reaction can be monitored visually or with the use of a spectrophotometer set in the visual spectrum (e.g., 400 millimicrons). When the reaction has reached completion, the salts from the buffer can be removed by dialysis and the soluble melanin can be stored at room temperature, frozen, or as a crystal or powder obtained through such procedures as natural evaporation or lyophilization. It is useful, but not mandatory, to enzymatically synthesize soluble melanin in the presence of a tyrosinase inhibitor such as phenylthiourea, because tyrosinase, which is occasionally present in the enzyme preparation, can cause the formation of insoluble melanin. Although phenylthiourea is a useful tyrosinase inhibitor because it does not inhibit or destroy the enzymes in question, the procedure is not restricted to phenylthiourea and any such tyrosinase inhibitor can be employed.
Soluble melanin prepared by the above procedure is golden-brown in color and absorbs widely throughout the ultraviolet and visible spectra (e.g., 220 to 700 millimicrons). The color can vary from brown-black in very concentrated solutions, to golden in more dilute solutions.
The addition of sulfhydryl-containing compounds such as cysteine or glutathione can impart a reddish color to the soluble melanin.
Fig. l depicts the enzymatic formation of soluble melanin. The contents of the three tubes on the right were filtered through a 0.4S micron filter, otherwise they were identical in composition to the contents of the three tubes on the left. Considering the three tubes on the left:
S~JBSTIl-~TE S~IEET
.. . ., .~ , ` :
.
` ` :. .: . ' , ' : . ` ` .. ` ;. . `
`; :. . ` `
,: ~ ~. . - .. ` .
WO92/16189 PCT/US91/0~64 ~ j,j 20 l) The far left-hand tube contained a mixture of dopachrome, dopa and 5,6-dihydroxyindole. It also contained the buffer used to dissolve the enzymes (sodium phosphate 5mM, pH 6.8, containing 20% glycerol vol/vol), but the enzymes themselves were not added.
2) The second tube from the left contained the same mixture as in the left-hand tube, but in addition it contained the enzymes dissolved in their buffer. The enzymes are referred to as "DI Complex".
3) The third tube from the left was identical to the middle tube, but also contained trypsin, a potent proteolytic enzyme, at a concentration of 0.5 mg/ml.
The three tubes on the left were incubated at room temperature for 6 hours before half their contents were removed and filtered as described above into the three right-hand tubes.
It can be seen that with buffer only, all the black melanin which formed was trapped on the filter, i.e., insoluble. When the DI Complex was added, the golden-brown melanin was completely filterable, i.e., soluble. When trypsin was present, no soluble melanin was formed, indicating that the soluble melanin production was catalyzed by a protein (enzyme). Melanin prepared non-enzymatically are similar in appearance to those seen in the tubes labelled "DI Complex".
The soluble melanin provided in Example 3 have the following characteristics: -(l) are greater than molecular weight lO,000, ~-(2) are stable to boiling, -(3) are stable to freezing, (4) can be filtered through a filter at least as small as 0.45 microns, (5) are soluble in water at a pH range of at least 6.5 to 7.5 at temperatures from 0 to 100C, SlJBST~T~TE SHEET.
.. .. . . . . .
.... ~. . , .'.......... `: . .. ~.
. , . ~ . : ~, , ~
- ... . ., . - . . . ~
~ . . : , . : . . ,.. .. : :-. . - .. . . . . : , WO92~l6l89 ,~r~ ?~;P~US91/0~6 (6) can be precipitated below pH 4, (7) can be lyophilized to a crystal/powder ~orm which can be redissolved in water, (8) vary from brown-black to golden in color dependlng on concentration, (9) absorb throughout the ultraviolet and visible spectra and (10) can be prepared in red and yellow forms with the addition of sulfhydryl-containing compounds and various metal ions.
ExamDle 4: Non-Enzvmatic Svnthesis of Soluble Melanin Soluble melanin can be prepared in a nonenzymatic reaction by mixing 5,6-dihydroxyindole-2-carboxylic acid (DHICA) and 5,6-hydroxyindole (DHI) in the presence of oxygen in a non-destroying buffer (e.g., 0.1 molar sodium phosphate, pH 6.5 to 7.5) or by incubating DHICA alone at ambient temperature of any suitable non-destroying temperature which allows the reaction to occur (e.g., 15 to 37'C), until soluble melanin begins to appear (e.g., 3 to 6 hours). The soluble melanin thus formed is indistinguishable from that which is formed enzymatically as described in Example 3.
The difference between enzymatic and non-enzymatic synthesis of soluble melanin is that in the enzymatic synthesis, 5,6-dihydroxyindole-2-carboxyl acid is produced from dopachrome by the enzyme dopachrome isomerase, and 5,6-dihydroxyindole is prQduced spontaneously from dopachrome, while in the non-enzymatic synthesis, 5,6-dihydroxyindole-2-carboxylic acid (DHICA) and 5,6-dihydroxyindole are mixed directly to form soluble melanin or DHICA is incubated alone. In both the enzymatic and non-enzymatic procedures, the reaction is greatly enhanced by the presence of oxygen.
SU BSTITUTE SHEET
.
. ~ . . . .. . . -: -~ ~ - ., .' . ~.
~, WO92/16189 PCT/~'S91/0~64 ~ owever, once DHICA dissolves, it begins to spontaneously convert to soluble melanin. If it is to be used on the skin, then it should be in an oxygen-free vehicle. Accordingly, when not in use, store DHICA in a freezer, weighing out small amounts at time of use. DHICA
is much more stable at pH 6 than p~ 8.
~xam~le 5: SpectroDhotometric Ouantitation of Soluble Melanin Melanin was synthesized using a mixture of L-dopa, dopachrome, dihydroxyindole, and dihydroxyindole-2-carboxylic acid at concentrations of approximately 0.4 mg/ml dissolved in sodium phosphate, 0.lM, pH 6.8. The "DI
Complex" enzymes purified approximately 2,000 fold from 0.5 grams mouse melanoma tissue (see Example 3) were dissolved in buffer (sodium phosphate,`5 mM, pH 6.8) and incubated in a 4 ml reaction mix with the above substrates at room temperature for 5 hours. The control reaction had buffer only, with no enzymes added. In both reactions, melanin formation occurred, but when the enzymes were present, the melanin could be filtered through a 0.45 micron filter, whereas in the presence of buffer only, the melanin was insoluble and could not be filtered. Solutions were diluted 50 fold before measuring the optical density. A
photographic representation of this experiment is seen in Fig. l.
Figs. 2 to 4 show the optical spectrum of soluble melanin according to the present invention. In Figs. 2 to 4, the melanin exhibited a peak optical density (O.D.) at a wavelength of 310-320 nm. ~he spectra and O.D. were the same after the melanin had incubated under sterile conditions for 2 months at room temperature (20C), and whether or not the melanin was dialyzed or filtered through a 0.45 micron filter.
SlJBST~TUTE SHEET -~
,. . ..... , ... ~ .. : . . , . . . .. - ...... , , . :
,. . . . , . .
WO92/16189 PCT/~'S91/0~64 23 ~"ui,~
Note in Fig. 4 that relatively little soluble melanin is made when D~I plus DI are mixed together in the absence of any other added substrates. Note also, when DHI
plus DHICA are mixed together they make as much soluble melanin as when they are mixed additionally with DI, i.e., DI is not necessary in this case. Finally, note that a mixture of dopachrome and DHI in the absence of DI results in an insoluble precipitate (not shown here), but in the presence of DI results in the synthesis of soluble melanin.
This is because DI converts dopachrome to DHICA which then in turn combines with DHI in the presence of oxygen to form soluble melanin. In the absence of DI, dopachrome spontaneously converts to DHI and a precipitate (insoluble melanin) forms (see Scheme I hereinabove).
Figures 5 through 8 are described hereinabove.
Table l: S~ectro~hotometric Ouantitation of Soluble Melanin Optical DensitY at Wavelenath 320 nm Synthetic Route Before Filtration After Filtration Buffer only l.22 .024 (no enzymes added) Enzymes added 0.982 0.966 ExamDle 6: Transdermal Release Composition An admixture is prepared comprising the following:
.
Parts b wei ht Y q -.
Acrylamide copolymer 20 (e.g., "polytrap FLME 203") soluble melanin, as prepared according to Examples 3 or 4 5 ~JE3~TITUTE SHEET
. :
' ` -..................... . ~ . . . .
W092/16189 .~ PCT/US91/0 Alcohol 74.9 and a fraarance 0.1 The above mixture is applied to the skin, once a day, preferably in the morning, for two to four weeks.
;~ ','' ~,-''' . , ~
- . .:
~ ~ SUBST~TUTE SHEET :
W092/16189 ~ PC~/US91/0~ ~
~ ;J, ,~ J ~
ExamDle 7: Tanninq Oil A. An admixture is prepared by adding in the order indicated:
_ _ Parts by weiaht decylolcate 25.0 isopropyl myristate 15.0 and propylene glycol dicaprylate/
dicaprate 5.0 mineral oil 54.85 B. An admixture is prepared by adding 0.01 pbw soluble melanin, e.g., as prepared as described in Example 3 or 4, to 0.01 pbw of "SOLERTAN PB-10" (a poly(propylene glycol) lanolin ether).
C. The admixture of part B is added to the admixture of part A and the resultant admixture is mixed until homogeneous.
D. The composition of part C is applied to the skin once or twice daily for two to four weeks.
SIJBSTITUTE SHEET ~;
` . . ~ , .: : , ::., . ,,. -.
. " .. . . . -;
~J~ 26 Example 8: Suntannina Lotion An admixture was prepared containing the following:
Parts by weiaht ICI G-1800 5.0 (e.g., poly[oxyethylene]21 stearyl ether) isopropyl myristate lO.o preservative O.l stearyl alcohol 2.0 2-hydroxy-3,3,5-trimethylhexyl 8.0 t ester of benzoic acid butylated hvdroxvanisole _ 0.05 The above mixture is heated to 70C and 60 parts by weight of water, preheated to 70C is added thereto. the resultant mixture is stirred and allowed to cool to room temperature.
To the above mixture is then added a 1% citric acid solution, QS, to achieve a pH of 5.0 after which 0.01 parts by weight of a soluble melanin, for example, as prepared according to Example 3 or Example 4, is added, as well as sufficient deionized water to yield lO0 parts by weight of lotion. ~ `
The above lotion is applied to the skin one-half (l/2) hour prior to exposure to the sun. After swimming, sweating or toweling, as well as after each hour of exposure, the lotion is reapplied.
The soluble melanin of the present invention can - ~;
also be incorporated into foodstuffs as a coloring and/or flavoring agent, e.g. into coffee, tea, soda, beer, liquor, ice cream, frozen yogurt, barbecued potato chips, and the like. The amount added of course depends on the magnitude S~BsTlTll~E ~EET
...... .. .... .. . .... ... .... .
W~'~2/16189 PCT/US91/0~64 of the effect desired, but for liquids (beverages) it would be in the range of l-lO00 mg/liter and for solids (foodstuffs) it would be in the range of l-lO00 mg/kg. The amounts added would not be limited to these ranges.
It will be appreciated that the instant specification is set forth by way of illustration and not limitation, and that various modification and changes may be made without departing from the spirit and scope of the present invention.
SUBSTITUTE SHEET
., .. .. ~ - , .
` - ~ . .
. .
, ~ , - , ~,. . . . ~.
Claims (43)
1. A melanin that is soluble in an aqueous solution at a pH of at least 5 to 9 at a temperature of 0 to 100°C.
2. A melanin according to claim 1, wherein the pH
is 6.5 to 7.5.
is 6.5 to 7.5.
3. A melanin according to claim 1, wherein the melanin is capable of being filtered through at least a 0.45 micron size filter.
4. A melanin according to claim 1, wherein the melanin remains soluble upon boiling.
5. A melanin according to claim 1, wherein the melanin remains soluble upon freezing/thawing.
6. A melanin according to claim 1, wherein the melanin is capable of being precipitated below pH 4.
7. A melanin according to claim 1, wherein the melanin has a molecular weight of greater than 10,000 kilodaltons.
8. A melanin according to claim 1, wherein the aqueous solution is water.
9. A melanin according to claim 1, wherein the melanin exhibits a peak optical density at 310 to 320 nm and absorbs broadly throughout the visible and ultraviolet spectra.
10. A method of producing a soluble melanin comprising combining in a reaction mixture dopachrome and one or more enzymes derived from biological cells or tissues which contain a pigmentary system.
11. A method according to claim 10, wherein the reaction mixture further comprises 5,6-dihydroxyindole.
12. A method according to claim 10, wherein the reaction mixture further comprises indole-5,6-quinone.
13. A method according to claim 10, wherein the reaction mixture further comprises melanochrome.
14. A method according to claim 10, wherein the reaction mixture further comprises indole-5,6-quinone and melanochrome.
15. A method according to claim 10, wherein the enzyme is derived from a biological cell or tissue which has the ability to produce melanin and wherein said biological cell or tissue is contacted with an insoluble compound which attaches to molecular structures other than enzymes and does not destroy the activity of the enzymes.
16. A method according to claim 15, wherein the insoluble compound is calcium phosphate.
17. A method according to claim 10, wherein the enzyme is dopachrome isomerase.
18. A method according to claim 10, wherein the enzyme comprises dopachrome isomerase and one or more of glycoprotein 75 and MSH receptor.
19. A method according to claim 10, wherein the enzyme comprises a complex of tyrosinase, dopachrome isomerase, glycoprotein 75 and MSH receptor.
20. A method according to claim 10, wherein the enzyme comprises one or more individual enzymes or a complex thereof, said enzymes selected from the group consisting of tyrosinase, dopachrome isomerase, glycoprotein 75, MSH
receptor, and one or more additional enzymes which are distinct from tyrosinase, dopachrome isomerase, glycoprotein 75 and MSH receptor, and which enzyme is capable of catalyzing the synthesis of soluble melanin.
receptor, and one or more additional enzymes which are distinct from tyrosinase, dopachrome isomerase, glycoprotein 75 and MSH receptor, and which enzyme is capable of catalyzing the synthesis of soluble melanin.
21. A method according to claim 10, which further comprises conducting the method in the presence of oxygen.
22. A method of producing a soluble melanin comprising dissolving 5,6-dihydroxyindole-2-carboxylic acid in an aqueous buffer and aerating.
23. A method of producing a soluble melanin according to claim 22, wherein the reaction mixture further contains 5,6-dihydroxyindole.
24. A method according to claim 22, wherein the reaction mixture further comprises indole-5,6-quinone.
25. A method according to claim 22, wherein the reaction mixture further comprises melanochrome.
26. A method according to claim 22, wherein the reaction mixture further comprises indole-5,6-quinone and melanochrome.
27. A method according to claim 22, which further comprises conducting the method in the presence of oxygen.
28. A composition for a sun screen or for providing a naturally-appearing tan to mammalian skin or hair comprising a soluble melanin according to claim 1 in admixture with a physiologically acceptable carrier.
29. A method of providing a naturally-appearing tan to mammalian skin and hair comprising administering to a mammal an effective tan producing amount of a soluble melanin according to claim 1, either alone, or in admixture with a physiologically acceptable carrier.
30. A method according to claim 28, wherein said administering is by topical administration.
31. A method of providing a sun screen to mammalian skin and hair comprising administering to a mammal an effective tan producing amount of a soluble melanin according to claim 1, either alone, or in admixture with a physiologically acceptable carrier.
32. A method according to claim 30, wherein said administering is by topical administration.
33. A method of changing the color of a melanin that is soluble in an aqueous solution at a pH of at least 5 to 9 at a temperature of 0 to 100°C comprising adding at least one of a sulfhydryl-containing compounds and metal ions to said reaction mixture according to claim 10.
34. A method of changing the color of a melanin that is soluble in an aqueous solution at a pH of at least 5 to 9 at a temperature of 0 to 100°C comprising in a reaction mixture 5,6-dihydroxyindole-2-carboxylic acid.
35. A method of changing the color of a melanin that is soluble in an aqueous solution at a pH of at least 5 to 9 at a temperature of 0 to 100°C, which comprises altering the pH of the reaction mixture according to Claim 10 to at least between pH 5 and 9.
36. A method of changing the color of a melanin that is soluble in an aqueous solution at a pH of at least 5 to 9 at a temperature of 0 to 100°C, which comprises altering the pH of the reaction mixture according to Claim 22 to at least between pH 5 and 9.
37. A method of providing a naturally-appearing tan or for providing a sun-screen to mammalian skin or hair comprising individually topically administering to said skin or hair, 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole.
38. A method of tinting glass or plastic, which comprises incorporating into the glass or plastic an effective tint producing amount of a soluble melanin according to claim 1.
39. A method of protecting industrial materials against damage due to exposure to ultraviolet radiation, which comprises incorporating into the industrial materials an amount effective to protect against damage of a soluble melanin according to claim 1.
40. A method of treating post-inflammatory hypo-or hyperpigmentation, which comprises applying to the skin an amount effective to treat post-inflammatory hypo- or hyperpigmentation of a soluble melanin according to claim 1.
41. A kit for providing a naturally appearing tan or for providing a sun-screen to mammalian skin or hair comprising in separate containers or in a plurality of separate microspheres 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole.
42. A foodstuff colored with a soluble melanin according to claim 1.
43. A colored foodstuff according to claim 42 wherein the foodstuff comprises coffee, tea, soda, beer, liquor, ice cream, frozen yogurt or barbecued potato chips.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/603,111 US5218079A (en) | 1990-05-18 | 1990-10-25 | Soluble melanin |
US603,111 | 1990-10-25 | ||
US07/674,489 US5225435A (en) | 1990-05-18 | 1991-03-25 | Soluble melanin |
US674,489 | 1991-03-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2092205A1 true CA2092205A1 (en) | 1992-04-26 |
Family
ID=27084339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002092205A Abandoned CA2092205A1 (en) | 1990-10-25 | 1991-05-16 | Soluble melanin |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0548110A4 (en) |
CA (1) | CA2092205A1 (en) |
WO (1) | WO1992016189A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5227459A (en) * | 1990-05-18 | 1993-07-13 | Yale University | Synthetic melanin |
AU2771792A (en) * | 1992-03-31 | 1993-11-08 | Kyowa Hakko Kogyo Co. Ltd. | Novel cosmetic |
WO1994010968A1 (en) * | 1992-11-19 | 1994-05-26 | Bristol-Myers Squibb Company | Compositions and methods for temporarily coloring hair using solubilized melanin |
ZA937753B (en) * | 1992-11-19 | 1994-04-19 | Bristol Myers Squibb Co | Compositions and methods for temporarily coloring hair using chemically synthesized or biosynthetic water-soluble melanin |
US5643554A (en) * | 1993-04-30 | 1997-07-01 | Dusa Pharmaceuticals, Inc. | Lipomelanim composition |
US5744125A (en) * | 1993-08-19 | 1998-04-28 | Yale University | Cosmetic melanins |
DE4419427C2 (en) * | 1994-06-03 | 1998-02-26 | Extroverta S Vogel | Thermally aftertreated potato products, such as French fries, and method and device for their production |
US5686084A (en) * | 1995-12-06 | 1997-11-11 | Clairol Incorporated | Synthesis of quaternary melanin compounds and their use as hair dyes or for skin treatment |
US5702712A (en) * | 1995-12-06 | 1997-12-30 | Clairol, Incorporated | Melanoquaternary compounds and their use as hair dyes and for skin treatment |
US6300057B1 (en) * | 1997-02-06 | 2001-10-09 | Large Scale Biology Corporation | Melanins with improved ability to inhibit HIV replication |
WO2000055348A1 (en) * | 1999-03-17 | 2000-09-21 | Unilever Plc | Sunscreen composition |
FR2863620B1 (en) * | 2003-12-16 | 2007-05-25 | Roquette Freres | USE OF AT LEAST ONE 3 TO 5 CARBON ATOMES AS A SUBSTITUTE OF PROTEIN-RELATING AGENTS |
WO2007142502A1 (en) * | 2006-06-05 | 2007-12-13 | Arturo Solis Herrera | Method for the synthesis of soluble melanin from precursor amino acids |
BR102013001441B1 (en) * | 2013-01-21 | 2021-02-23 | Universidade Estadual Paulista " Julio De Mesquita Filho" - Unesp | production process of synthetic melanin and product obtained |
CN117337933B (en) * | 2023-10-26 | 2025-09-09 | 中南林业科技大学 | Coloring method of bean products |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4515773A (en) * | 1983-07-05 | 1985-05-07 | Repligen Corporation | Skin tanning composition and method |
LU86474A1 (en) * | 1986-06-16 | 1988-01-20 | Oreal | TINCTORIAL COMPOSITION FOR HUMAN KERATINIC FIBERS IN THE FORM OF FOAM, BASED ON 5,6-DIHYDROXYINDOLE |
US4806344A (en) * | 1987-01-05 | 1989-02-21 | Gaskin Frances C | Sun protectant composition and method |
JP2566808B2 (en) * | 1988-03-15 | 1996-12-25 | 花王株式会社 | Hair dye composition and hair dyeing method |
CA1333690C (en) * | 1988-05-12 | 1994-12-27 | Thomas Matthew Schultz | Process for dyeing hair by the sequential treatment with metal ion containing composition and dye composition containing 5,6-dihydroxyindole-2-carboxylic acid |
LU87270A1 (en) * | 1988-07-08 | 1990-02-07 | Oreal | PROCESS FOR DYEING KERATINIC FIBERS WITH 5,6-DIHYDROXYINDOLE ASSOCIATED WITH A NITRITE AND COMPOSITION FOR USE |
US4968497A (en) * | 1988-08-26 | 1990-11-06 | Clairol Incorporated | Skin tanning composition and method |
AU4418989A (en) * | 1988-10-03 | 1990-05-01 | Biosource Genetics Corporation | Melanin production |
US5057325A (en) * | 1990-03-20 | 1991-10-15 | Vanderbilt University | Method of inhibiting replication of HIV with water-soluble melanins |
US5216116A (en) * | 1990-05-18 | 1993-06-01 | Yale University | Soluble melanin |
-
1991
- 1991-05-16 CA CA002092205A patent/CA2092205A1/en not_active Abandoned
- 1991-05-16 EP EP91915223A patent/EP0548110A4/en not_active Withdrawn
- 1991-05-16 WO PCT/US1991/003464 patent/WO1992016189A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1992016189A1 (en) | 1992-10-01 |
EP0548110A4 (en) | 1994-12-14 |
EP0548110A1 (en) | 1993-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5225435A (en) | Soluble melanin | |
US5218079A (en) | Soluble melanin | |
US5227459A (en) | Synthetic melanin | |
US5216116A (en) | Soluble melanin | |
CA2092205A1 (en) | Soluble melanin | |
ORLOW et al. | Synthesis and characterization of melanins from dihydroxyindole‐2‐carboxylic acid and dihydroxyindole | |
CA2105280C (en) | Product based on coloured mineral particles including a mecanic pigment; process for preparing same and application in cosmetics | |
KR100478928B1 (en) | Non-medicinal antioxidants containing sericin or sericin hydrolyzate as an active ingredient, cosmetics, food discoloration prevention, food, myocardial infarction, arteriosclerosis, diabetes treatment, cancer treatment, or stroke treatment | |
CN114306113B (en) | Supermolecular carnosine, composition containing supermolecular carnosine, and preparation methods and applications thereof | |
EP1392840A2 (en) | Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same | |
WO1995009629A1 (en) | Synthetic melanin | |
US5583234A (en) | Indoline-based products, processes for preparing them and their use in cosmetics | |
KR20230158328A (en) | Cosmetic composition for antioxidation, skin-whitening and anti-wrinkle comprising rice by-product extracts fermented by lactic acid bacteria | |
JPH06183936A (en) | Compound, composition and method for coloring hair or skin | |
JPH03220115A (en) | Hair dyeing cosmetic | |
CN109646389B (en) | Flavobacterium fermentation extract and application thereof in cosmetics | |
Saito et al. | Photostabilization of phycocyanin and anthocyanin in the presence of biopterin-α-glucoside from Spirulina platensis under ultraviolet ray | |
JPH06505960A (en) | soluble melanin | |
US7135184B2 (en) | Culture having phenol oxidase-like activity | |
EP1602718A1 (en) | Neutral phenol oxidase | |
KR20020023168A (en) | Whitening Materials from Extracts of Gardenia Fruit | |
AU7564094A (en) | Cosmetic melanins | |
JPS61194007A (en) | External preparation for skin | |
KR101949937B1 (en) | Anti-aging Composition for Skin External Application Comprising Callus extracts from Citrus junos Siebold ex Tanaka and Pyrus pyrifolia Nakai and Xanthan Gum | |
US6315988B1 (en) | Process for preparing protein-bound melanin and/or peptide bound melanin, and products thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |